[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Next Issue
Volume 28, March-1
Previous Issue
Volume 28, February-1
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
molecules-logo

Journal Browser

Journal Browser

Molecules, Volume 28, Issue 4 (February-2 2023) – 484 articles

Cover Story (view full-size image): The complexation abilities of cucurbiturils (CBs) could be enhanced with the assistance of metal cations, which can exert a dual effect on the complexation process: either by competitively binding to the host entity or cooperatively associating to the CB[n]-guest structures. The current study focuses on the role of two metal species (Mg2+ and Ga3+) in the complex formation of CBs with three dye molecules: Thiazole Orange, Neutral Red, and Thioflavin T. Various key factors influencing the process have been recognized such as the pH and dielectric constant of the medium, cavity size of the host, Mn+ charge, and presence/absence of hydration shell around the metal cation. The results obtained from density functional theory (DFT) calculations shed new light on several aspects of the cucurbituril complexation chemistry. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
26 pages, 6377 KiB  
Review
Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases
by Alyssa Padilla, John F. Manganaro, Lydia Huesgen, Deborah A. Roess, Mark A. Brown and Debbie C. Crans
Molecules 2023, 28(4), 2000; https://doi.org/10.3390/molecules28042000 - 20 Feb 2023
Cited by 7 | Viewed by 4589
Abstract
A comprehensive understanding of the mechanisms involved in epigenetic changes in gene expression is essential to the clinical management of diseases linked to the SMYD family of lysine methyltransferases. The five known SMYD enzymes catalyze the transfer of donor methyl groups from S-adenosylmethionine [...] Read more.
A comprehensive understanding of the mechanisms involved in epigenetic changes in gene expression is essential to the clinical management of diseases linked to the SMYD family of lysine methyltransferases. The five known SMYD enzymes catalyze the transfer of donor methyl groups from S-adenosylmethionine (SAM) to specific lysines on histones and non-histone substrates. SMYDs family members have distinct tissue distributions and tissue-specific functions, including regulation of development, cell differentiation, and embryogenesis. Diseases associated with SMYDs include the repressed transcription of SMYD1 genes needed for the formation of ion channels in the heart leading to heart failure, SMYD2 overexpression in esophageal squamous cell carcinoma (ESCC) or p53-related cancers, and poor prognosis associated with SMYD3 overexpression in more than 14 types of cancer including breast cancer, colon cancer, prostate cancer, lung cancer, and pancreatic cancer. Given the importance of epigenetics in various pathologies, the development of epigenetic inhibitors has attracted considerable attention from the pharmaceutical industry. The pharmacologic development of the inhibitors involves the identification of molecules regulating both functional SMYD SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) and MYND (Myeloid-Nervy-DEAF1) domains, a process facilitated by available X-ray structures for SMYD1, SMYD2, and SMYD3. Important leads for potential pharmaceutical agents have been reported for SMYD2 and SMYD3 enzymes, and six epigenetic inhibitors have been developed for drugs used to treat myelodysplastic syndrome (Vidaza, Dacogen), cutaneous T-cell lymphoma (Zoinza, Isrodax), and peripheral T-cell lymphoma (Beleodag, Epidaza). The recently demonstrated reversal of SMYD histone methylation suggests that reversing the epigenetic effects of SMYDs in cancerous tissues may be a desirable target for pharmacological development. Full article
(This article belongs to the Special Issue Exploring Bioactive Organic Compounds for Drug Discovery)
Show Figures

Figure 1

Figure 1
<p>Representations of the five SMYD proteins where the SET domain is split by the MYND domain. Adopted with permission from Ref. [<a href="#B6-molecules-28-02000" class="html-bibr">6</a>].</p>
Full article ">Figure 2
<p>Domain structures of SMYD1, SMYD2, and SMYD3 proteins. (<b>A</b>) Ribbon diagrams of SMYD1 (PDB code: 3N71), SMYD2 (PDB code: 3QWV and 3QWW), and SMYD3 (PDB code: 3PDN). The sequences starting at the N-terminal S show the MYND, SET-I, ET, post-SET, and CTD/C-lobe domains. These are in light green, blue, pink, green, cyan, and red, respectively. Secondary structures, α-helices, and β-strands are labeled and numbered according to their position in the sequence of the SMYD1 structure. Cofactor analogs, including sinefungin (SFG) and S-adenosyl-L-homocysteine (SAH), are depicted as balls and sticks. (<b>B</b>) The three SMYD proteins are superimposed, beginning at the N-terminal lobe with SMYD1 shown in pink, SFG-SMYD2 shown in cyan, SAH-SMYD2 shown in green and SMYD3 shown in yellow [<a href="#B29-molecules-28-02000" class="html-bibr">29</a>].</p>
Full article ">Figure 3
<p>The expression of SMYD1 in wild type (WT) mouse embryos. (<b>A</b>,<b>B</b>) shows whole-mount in situ hybridization shows the expression of SMYD1 in the ventricle (V), left ventricle (LV), right ventricle (RV), and outflow tract (OFT) of a mouse embryo heart at E8.5 and E9.0. Image licensed under CC-BY 4.0; Ref. [<a href="#B17-molecules-28-02000" class="html-bibr">17</a>].</p>
Full article ">Figure 4
<p>Regulation of histone modification patterns by skNAC and SMYD1 measured using an ELISA and a Western blot. A decrease in H3K4me2 is observed when cells had been transfected with SMYD1 siRNA and to a lesser extent with skNAC-specific siRNA. Adopted with permission from Elsevier Ref. [<a href="#B93-molecules-28-02000" class="html-bibr">93</a>]. Data are expressed as mean ± SD (<span class="html-italic">n</span> = 3). * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 5
<p>SMYD2 is involved in cancers and other diseases via the methylation of nonhistone substrates. Proteins methylated by SMYD2 during cancer development include p53, RB, PTEN, ALK, MAPKAPK3, HSP90AB1, ERα, and PARP1. SMYD2 methylates and activates p65 and STAT3 to regulate autosomal dominant polycystic kidney disease. The methylation of BMPR2 by SMYD2 activates SMAD1/5 signaling. The methylation of substrates also leads to crosstalk between signaling pathways undergoing other posttranslational modifications, particularly phosphorylation. This affects cell proliferation and differentiation and target genes related to cancer and other diseases. Adopted with permission from Ref. [<a href="#B9-molecules-28-02000" class="html-bibr">9</a>].</p>
Full article ">Figure 6
<p>Cardiomyocytes, treated with CoCl2 to induce apoptosis, demonstrated downregulation of SMYD2 and accumulation of p53. **: ± SEM, <span class="html-italic">n</span> = 3. Adopted with permission from Elsevier Ref. [<a href="#B103-molecules-28-02000" class="html-bibr">103</a>].</p>
Full article ">Figure 7
<p>SMYD2 mRNA expression in leukemic bone marrow samples is abnormally high when compared with non-neoplastic samples. Boxplot representation of SMYD2 mRNA expression quantification by qPCR. mRNA levels were measured in leukemic samples and non-malignant bone marrow. <span class="html-italic">y</span> axis, RQ value for SMYD2 after ACTB normalization. <span class="html-italic">x</span> axis, sample type (<span class="html-italic">n</span> = 83 for leukemia samples and <span class="html-italic">n</span> = 8 for non-malignant bone marrow samples). Based on the log normal distribution of SMYD2 expression level, five samples represented by circles were defined as outliers according to the outlier labeling rule. Adopted with permission from Ref. [<a href="#B19-molecules-28-02000" class="html-bibr">19</a>].</p>
Full article ">Figure 8
<p>The structure of the SMYD2, bound to the ERα peptide and SAH. (<b>a</b>) A ribbon diagram is shown of the SMYD2–ERα structure, side view (left) and top view (right). The S-sequence, MYND, SET-I, core SET, post-SET, and CTD are indicated in light green, blue, pink, green, cyan, and red. The α-helices and β-strands are labeled numerically. The ERα peptide, SAH, and a polyphenol glycol molecule (PEG) are displayed as sticks, with their carbon atoms colored yellow, white, and light blue. Zinc ions are shown by spheres and are colored purple. (<b>b</b>) A surface representation of the SMYD2–ERα structure, side view (left) and top view (right). SMYD2 is represented by the molecular surface, which is colored according to indicated domains. The ERα peptide, SAH, and PEG molecules are represented as stick molecules, as in (<b>a</b>). Image licensed by CC-BY 4.0 Ref. [<a href="#B107-molecules-28-02000" class="html-bibr">107</a>].</p>
Full article ">Figure 9
<p>The binding pocket of SMYD3 and predicted inhibitor 4 interactions. Hydrophilic amino acids are light blue and hydrophobic amino acids are yellow. (<b>A</b>) Inhibitor 4 structure; (<b>B</b>) Hydrophobic binding pocket indicated by a surface model; (<b>C</b>) Inhibitor 4 in binding pocket; (<b>D</b>) Amino acid residues in binding pocket, with hydrophobic interactions in yellow interacting with SAH in green, followed by a ring of blue hydrophilic residues; (<b>E</b>) Magenta inhibitor 4’s projected interactions with residues in binding pocket and the H-bonds shown in green. Image licensed by CC-BY 4.0 Ref. [<a href="#B32-molecules-28-02000" class="html-bibr">32</a>].</p>
Full article ">Figure 10
<p>Domain structures of both the human SMYD4 and the Drosophila homologue, dSMYD4. Image licensed under CC-BY 4.0 Ref. [<a href="#B77-molecules-28-02000" class="html-bibr">77</a>].</p>
Full article ">Figure 11
<p>(<b>a</b>) A widespread decrease in H4K20me3 occurs with SMYD5 knock down. (<b>b</b>) The ChIP-Seq Tag density of H3K20me3 is lowered when compared to the control. Image licensed under CC-BY 4 Ref. [<a href="#B85-molecules-28-02000" class="html-bibr">85</a>].</p>
Full article ">Scheme 1
<p>Methylation of histone lysine residues. (<b>A</b>) Monomethylation [<a href="#B4-molecules-28-02000" class="html-bibr">4</a>]. (<b>B</b>) Protein lysine methyltransferases (PKMTs) catalyze monomethylation (Kme1), dimethylation (Kme2), and trimethylation (Kme3) of proteins on the ε-amine group of theoretical independent lysine residue, using SAM as the primary methyl group donor and S-adenosyl-L-homocysteine (SAH). This modification is reversible and can be reversed by protein lysine demethylases (PKDMs) [<a href="#B9-molecules-28-02000" class="html-bibr">9</a>,<a href="#B12-molecules-28-02000" class="html-bibr">12</a>].</p>
Full article ">Scheme 2
<p>The structures for early leads for SMYD2 (AZ50552 [<a href="#B45-molecules-28-02000" class="html-bibr">45</a>]) and SMYD3 (BCI-121 [<a href="#B42-molecules-28-02000" class="html-bibr">42</a>] and EP2031686 [<a href="#B46-molecules-28-02000" class="html-bibr">46</a>]). There are as of yet no reported inhibitors for SMYD1, SMYD4 and SMYD5 Ref. [<a href="#B6-molecules-28-02000" class="html-bibr">6</a>] However, modulation of SMYD1 function was demonstrated by treatment with the anticancer agent anthracycline doxorubicin (DOX).</p>
Full article ">Scheme 3
<p>The structures for another lead for SMYD2 in the benzoxazinone series (A-89361 [<a href="#B54-molecules-28-02000" class="html-bibr">54</a>]) and a lead in the pyrrolidine series (LLY-50762 [<a href="#B55-molecules-28-02000" class="html-bibr">55</a>]).</p>
Full article ">Scheme 4
<p>Structures of SMYD3 inhibitors BCI-121 [<a href="#B116-molecules-28-02000" class="html-bibr">116</a>], EPZ031686 [<a href="#B46-molecules-28-02000" class="html-bibr">46</a>], EPZ030456 [<a href="#B46-molecules-28-02000" class="html-bibr">46</a>], EPZ028862 [<a href="#B116-molecules-28-02000" class="html-bibr">116</a>], GSK-49 [<a href="#B117-molecules-28-02000" class="html-bibr">117</a>], and BAY-6035 [<a href="#B116-molecules-28-02000" class="html-bibr">116</a>].</p>
Full article ">Scheme 5
<p>Representative newly reported inhibitors for SMYD3: BAY-598 [<a href="#B118-molecules-28-02000" class="html-bibr">118</a>]; inhibitor 29 [<a href="#B44-molecules-28-02000" class="html-bibr">44</a>] and inhibitor 4 [<a href="#B43-molecules-28-02000" class="html-bibr">43</a>].</p>
Full article ">
15 pages, 5016 KiB  
Article
Femtosecond Time-Resolved Observation of Relaxation and Wave Packet Dynamics of the S1 State in Electronically Excited o-Fluoroaniline
by Bumaliya Abulimiti, Huan An, Zhenfei Gu, Xulan Deng, Bing Zhang, Mei Xiang and Jie Wei
Molecules 2023, 28(4), 1999; https://doi.org/10.3390/molecules28041999 - 20 Feb 2023
Cited by 1 | Viewed by 2125
Abstract
Quantum beat frequency is the basis for understanding interference effects and vibrational wave packet dynamics and has important applications. Using femtosecond time-resolved mass spectrometry and femtosecond time-resolved photoelectron image combined with theoretical calculations, we study the electronic excited-state relaxation of o-fluoraniline molecule [...] Read more.
Quantum beat frequency is the basis for understanding interference effects and vibrational wave packet dynamics and has important applications. Using femtosecond time-resolved mass spectrometry and femtosecond time-resolved photoelectron image combined with theoretical calculations, we study the electronic excited-state relaxation of o-fluoraniline molecule and the time-dependent evolution of vibrational wave packets between different eigenstates. After the molecule absorbs a photon of 288.3 nm and is excited to the S1 state, intramolecular vibrational redistribution first occurs on the time scale τ1 = 349 fs, and then the transition to the triplet state occurs through the intersystem crossing on the time scale τ2 = 583 ps, and finally, the triplet state occurs decays slowly through the time scale τ3 = 2074 ps. We find the intramolecular vibrational redistribution is caused by the 00, 10b1 and 16a1 vibrational modes of the Sl state origin. That is, the 288.3 nm femtosecond laser excites the molecule to the S1 state, and the continuous flow of the vibrational wave packet prepares a coherent superposition state of three vibrational modes. Through extracting the oscillation of different peak intensities in the photoelectron spectrum, we observe reversible changes caused by mutual interference of the S1 00, S1 10b1 and S1 16a1 states when the wave packets flow. When the pump pulse is 280 nm, the beat frequency disappears completely. This is explained in terms of increases in the vibrational field density and characteristic period of oscillation, and statistical averaging makes the quantum effect smooth and indistinguishable. In addition, the Rydberg component of the S1 state is more clearly resolved by combining experiment and theory. Full article
Show Figures

Figure 1

Figure 1
<p><span class="html-italic">o</span>-Fluoroaniline energy varies with angle, and the five structures of the molecule are given. Calculation method and basis set: DFT and CAM-B3LYP/6-311+G(d,p).</p>
Full article ">Figure 2
<p>MO29, MO30, MO32 orbitals of <span class="html-italic">o</span>-fluoroaniline S<sub>1</sub> state. Calculation method and basis set: TD-DFT and CAM-B3LYP/6-311+G(d,p).</p>
Full article ">Figure 3
<p>Time decay curves of the parent ion measured with (<b>a</b>) a 288.3 nm pump pulse and 800 nm probe pulse, (<b>b</b>) a 280 nm pump pulse and 800 nm probe pulse. The circles are experimental data, and the solid lines are fitted data. Both curves are fitted using a Gaussian cross-correlation function and a convolution of three exponential decay functions, resulting in different decay times.</p>
Full article ">Figure 4
<p>Photoelectron spectra at delay times of (<b>a</b>) Δt = 0.027 ps and (<b>b</b>) Δt = 1.429 ps. The ordinates of the two plots are normalized, and (<b>b</b>) is normalized with the maximum value of (<b>a</b>) as a reference. The insets are the corresponding optoelectronic images (the original image on the left and BASEX transformed image on the right).</p>
Full article ">Figure 5
<p>Time decay curves of the parent ion measured with (<b>a</b>) 266 nm pump pulse and 800 nm probe pulse, (<b>b</b>) 260 nm pump pulse and 800 nm probe pulse, (<b>c</b>) 250 nm pump pulse and 800 nm probe pulse, and (<b>d</b>) 240 nm pump pulse and 800 nm probe pulse. The circles are experimental data, and the solid lines are fitted data. All curves are fitted using a Gaussian cross-correlation function and a convolution of three exponential decay functions to obtain different decay times.</p>
Full article ">Figure 6
<p>(<b>a</b>) Time-resolved photoelectron spectrum obtained with a 288.3 nm pump pulse and 800 nm probe pulse. (<b>b</b>) The spectrum obtained by Fourier transform of the residual data at the fourth peak. (<b>c</b>) Signal intensities of the six peaks as functions of delay time. Experimental data are given as open circles, while solid lines are fitted results.</p>
Full article ">Figure 7
<p>(<b>a</b>) Time-resolved photoelectron spectrum obtained with 280 nm pump pulse and 800 nm probe pulse. (<b>b</b>) Signal intensities of the six peaks as functions of delay time. Experimental data are given as open circles, while solid lines are fitted results.</p>
Full article ">Figure A1
<p>The infrared spectrum of the ground state, S<sub>1</sub> state, and T<sub>1</sub> state of the molecule shows no imaginary frequency. For the S<sub>0</sub> state, calculation method and basis set: DFT and CAM-B3LYP/6-311+G(d,p). For S<sub>1</sub> and T<sub>1</sub> states, calculation method and basis set: TD-DFT and CAM-B3LYP/6-311+G(d,p).</p>
Full article ">Figure A2
<p>Molecular structure and Cartesian coordinate system of the ground state, S<sub>1</sub> state and T<sub>1</sub> state, and the Z axis is perpendicular to the paper surface. For the S<sub>0</sub> state, calculation method and basis set: DFT and CAM-B3LYP/6-311+G(d,p). For S<sub>1</sub> and T<sub>1</sub> states, calculation method and basis set: TD-DFT and CAM-B3LYP/6-311+G(d,p).</p>
Full article ">Figure A3
<p>The molecular orbitals of the first to the fifth and eighth peaks.</p>
Full article ">
35 pages, 6797 KiB  
Review
Synthesis and Application Dichalcogenides as Radical Reagents with Photochemical Technology
by Cairong Wang, Yan Zhang, Kai Sun, Tingting Yu, Fei Liu and Xin Wang
Molecules 2023, 28(4), 1998; https://doi.org/10.3390/molecules28041998 - 20 Feb 2023
Cited by 6 | Viewed by 3278
Abstract
Dichalcogenides (disulfides and diselenides), as reactants for organic transformations, are important and widely used because of their potential to react with nucleophiles, electrophilic reagents, and radical precursors. In recent years, in combination with photochemical technology, the application of dichalcogenides as stable radical reagents [...] Read more.
Dichalcogenides (disulfides and diselenides), as reactants for organic transformations, are important and widely used because of their potential to react with nucleophiles, electrophilic reagents, and radical precursors. In recent years, in combination with photochemical technology, the application of dichalcogenides as stable radical reagents has opened up a new route to the synthesis of various sulfur- and selenium-containing compounds. In this paper, synthetic strategies for disulfides and diselenides and their applications with photochemical technology are reviewed: (i) Cyclization of dichalcogenides with alkenes and alkynes; (ii) direct selenylation/sulfuration of C−H/C−C/C−N bonds; (iii) visible-light-enabled seleno- and sulfur-bifunctionalization of alkenes/alkynes; and (iv) Direct construction of the C(sp)–S bond. In addition, the scopes, limitations, and mechanisms of some reactions are also described. Full article
(This article belongs to the Special Issue Synthesis and Modification of Nitrogen Heterocyclic Compounds)
Show Figures

Figure 1

Figure 1
<p>Summary of recent synthetic strategies for disulfides and diselenides.</p>
Full article ">Scheme 1
<p>Visible-light-promoted synthesis of <span class="html-italic">β</span>-selenyl <span class="html-italic">O</span>-heterocycles and <span class="html-italic">N</span>-heterocycles.</p>
Full article ">Scheme 2
<p>Visible-light-promoted synthesis of spiro [<a href="#B4-molecules-28-01998" class="html-bibr">4</a>,<a href="#B5-molecules-28-01998" class="html-bibr">5</a>] trienones.</p>
Full article ">Scheme 3
<p>Visible-light-induced cascade reaction of alkyne-tethered cyclohexadienones and diselenides.</p>
Full article ">Scheme 4
<p>Ru (II) catalyzed, photochemical synthesis of <span class="html-italic">β</span>-organoselenyl cyclopentanones.</p>
Full article ">Scheme 5
<p>Visible-light-induced cross-coupling cyclization.</p>
Full article ">Scheme 6
<p>Spirocyclization of homologated-ynones.</p>
Full article ">Scheme 7
<p>Visible-light-promoted synthesis of 3-selenospiroindolenines.</p>
Full article ">Scheme 8
<p>Visible-light-promoted synthesis of seleno-containing pyrrolidines.</p>
Full article ">Scheme 9
<p>Photoinduced cyclizations of <span class="html-italic">o</span>-diisocyanoarenes with diselenides.</p>
Full article ">Scheme 10
<p>Photoinduced regio- and chemoselective radical cyclization of unactivated 1,6-enynes with selenides.</p>
Full article ">Scheme 11
<p>Synthesis of benzo heterocycles.</p>
Full article ">Scheme 12
<p>Synthesis of benzofurans.</p>
Full article ">Scheme 13
<p>(NH<sub>4</sub>)S<sub>2</sub>O<sub>8</sub> mediated photoinduced selenylation coumarins.</p>
Full article ">Scheme 14
<p>RB catalyzed photochemical selenylation of indoles and (hetero)arenes.</p>
Full article ">Scheme 15
<p>Blue LEDs induced C(sp<sup>2</sup>)−H bond selenylation of indoles and activated arenes.</p>
Full article ">Scheme 16
<p>Photoinduced metal-free <span class="html-italic">α</span>-selenylation of ketones.</p>
Full article ">Scheme 17
<p>Visible-light-mediated C(sp<sup>2</sup>)−H selenylation.</p>
Full article ">Scheme 18
<p>Visible-light-induced direct thiolation of ether with disulfides at <span class="html-italic">α</span>-C(sp<sup>3</sup>)−H.</p>
Full article ">Scheme 19
<p>Light mediated C(sp<sup>2</sup>)−H bond chalcogenation (S, Se,) of indoles.</p>
Full article ">Scheme 20
<p>Direct thiolation of allyl C(sp<sup>3</sup>)−H.</p>
Full article ">Scheme 21
<p>Site-selective thiolation of (multi)halogenated heteroarenes.</p>
Full article ">Scheme 22
<p>Visible-light photoredox synthesis of chiral <span class="html-italic">α</span>-selenoamino acids.</p>
Full article ">Scheme 23
<p>Photochemical C(sp<sup>3</sup>)−Se bond formation through C−C bond cleavage of cyclobutanone oxime esters.</p>
Full article ">Scheme 24
<p>Blue LEDs mediated seleno-substitutions of azosulfone group.</p>
Full article ">Scheme 25
<p>Visible-light-catalyzed synthesis of asymmetric selenides from pyridinium salts.</p>
Full article ">Scheme 26
<p>Sulfurization of aryl hydrazines.</p>
Full article ">Scheme 27
<p>Photochemical regioselective hydroselenylation of terminal alkynes.</p>
Full article ">Scheme 28
<p>Visible-light-mediated cascading reactions construct C−Se and C−S bonds simultaneously.</p>
Full article ">Scheme 29
<p>Visible-light-induced difunctionalization of styrenes with a binary system of diaryl diselenides and carboxylic acids.</p>
Full article ">Scheme 30
<p>Synthesis of <span class="html-italic">β</span>-hydroxysulfide and <span class="html-italic">β</span>-alkoxysulfide.</p>
Full article ">Scheme 31
<p>Synthesis of alkynyl sulfides.</p>
Full article ">
26 pages, 5685 KiB  
Article
Synthesis of New Amino-Functionalized Porphyrins:Preliminary Study of Their Organophotocatalytic Activity
by Pol Torres, Marian Guillén, Marc Escribà, Joaquim Crusats and Albert Moyano
Molecules 2023, 28(4), 1997; https://doi.org/10.3390/molecules28041997 - 20 Feb 2023
Cited by 5 | Viewed by 4166
Abstract
The design, synthesis, and initial study of amino-functionalized porphyrins as a new class of bifunctional catalysts for asymmetric organophotocatalysis is described. Two new types of amine–porphyrin hybrids derived from 5,10,15,20-tetraphenylporphyrin (TPPH2), in which a cyclic secondary amine moiety is covalently linked [...] Read more.
The design, synthesis, and initial study of amino-functionalized porphyrins as a new class of bifunctional catalysts for asymmetric organophotocatalysis is described. Two new types of amine–porphyrin hybrids derived from 5,10,15,20-tetraphenylporphyrin (TPPH2), in which a cyclic secondary amine moiety is covalently linked either to a β-pyrrolic position (Type A) or to the p-position of one of the meso phenyl groups (Type B), were prepared by condensation, reductive amination, or amidation reactions from the suitable porphyrins (either formyl or methanamine derivatives) with readily available chiral amines. A preliminary study of the possible use of Type A amine–porphyrin hybrids as asymmetric, bifunctional organophotocatalysts was performed using the chiral, imidazolidinone-catalyzed Diels–Alder cycloaddition between cyclopentadiene 28 and trans-cinnamaldehyde 29 as a benchmark reaction. The yield and the stereochemical outcome of this process, obtained under purely organocatalytic conditions, under dual organophocatalysis, and under bifunctional organophotocatalysis, were compared. Full article
(This article belongs to the Special Issue Porphyrin-Based Compounds: Synthesis and Application)
Show Figures

Figure 1

Figure 1
<p>Amphiphilic Secondary Amine–porphyrin hybrids for pH-switchable aqueous organocatalysis.</p>
Full article ">Figure 2
<p>Secondary amine-TPPH<sub>2</sub> hybrids for bifunctional organophotocatalysis.</p>
Full article ">Figure 3
<p>Porphyrines and chiral imidazolidinones used in the dual organophotocatalyzed asymmetric Diels–Alder cycloaddition. See <a href="#molecules-28-01997-sch001" class="html-scheme">Scheme 1</a> for the structure of <b>TPPH<sub>2</sub></b>.</p>
Full article ">Figure 4
<p>Experimental setting for the photocatalytic reactions. LED coil (white light, 18 W, 1080 lumens), stirring plate. Left: Without fan. Right: With fan.</p>
Full article ">Scheme 1
<p>Preparation of 2-formyl-5,10,15,20-tetraphenylporphyrin <b>1</b> and its Cu(II) complex <b>3</b>.</p>
Full article ">Scheme 2
<p>Synthesis of 2-((2<span class="html-italic">R</span>,4<span class="html-italic">S</span>)-1,4-dimethyl-5-oxoimidazolidin-2-yl)-5,10,15,20-tetraphenylporphyrin <b>6a</b>. The symbol (*) indicates a stereogenic center of undetermined configuration.</p>
Full article ">Scheme 3
<p>Synthesis of imidazolidinone-porphyrin hybrids <b>6b</b> and <b>6b’</b>. The symbol (*) indicates a stereogenic center of undetermined configuration.</p>
Full article ">Scheme 4
<p>Synthesis of 2-((2<span class="html-italic">R</span>,4<span class="html-italic">S</span>)-4-(<span class="html-italic">tert</span>-butyl)-1-methyl-5-oxoimidazolidin-2-yl)-5,10,15,20-tetraphenylporphyrin <b>6c</b>.</p>
Full article ">Scheme 5
<p>Synthesis of 5-(4-formylphenyl)-10,15,20-triphenylporphyrin <b>2</b> and its Cu(II) derivative <b>10</b>.</p>
Full article ">Scheme 6
<p>Attempted synthesis of imidazolidinones derived from <b>2</b> and <b>10</b>.</p>
Full article ">Scheme 7
<p>Synthesis of (<span class="html-italic">S</span>)-<span class="html-italic">N</span>-<span class="html-italic">tert</span>-butyloxycarbonyl (2-aminomethyl)pyrrolidine <b>18</b>.</p>
Full article ">Scheme 8
<p>Synthesis of (<span class="html-italic">S</span>)-5,10,15-triphenyl-20-(4-(((2-(pyrrolidin-2-yl)ethyl)amino)methyl)phenyl)porphyrin <b>20</b>.</p>
Full article ">Scheme 9
<p>Reductive amination of <b>10</b> with the pyrrolidine derivative <b>18</b>.</p>
Full article ">Scheme 10
<p>Synthesis of 5,10,15-triphenyl-20-((<span class="html-italic">S</span>)-4-((pyrrolidine-2-carboxamido)methyl)phenyl)porphyrin <b>27</b>.</p>
Full article ">Scheme 11
<p>Chiral imidazolidinone-catalyzed, asymmetric Diels–Alder cycloaddition.</p>
Full article ">Scheme 12
<p>Speculative reaction pathway for the bifunctional organophotocatalysis of the Diels–Alder cycloaddition (TPP = 5,10,15,20-tetraphenylporphyrin-2-yl).</p>
Full article ">
21 pages, 2820 KiB  
Article
From Aquaculture to Aquaculture: Production of the Fish Feed Additive Astaxanthin by Corynebacterium glutamicum Using Aquaculture Sidestream
by Ina Schmitt, Florian Meyer, Irene Krahn, Nadja A. Henke, Petra Peters-Wendisch and Volker F. Wendisch
Molecules 2023, 28(4), 1996; https://doi.org/10.3390/molecules28041996 - 20 Feb 2023
Cited by 9 | Viewed by 3519
Abstract
Circular economy holds great potential to minimize the use of finite resources, and reduce waste formation by the creation of closed-loop systems. This also pertains to the utilization of sidestreams in large-scale biotechnological processes. A flexible feedstock concept has been established for the [...] Read more.
Circular economy holds great potential to minimize the use of finite resources, and reduce waste formation by the creation of closed-loop systems. This also pertains to the utilization of sidestreams in large-scale biotechnological processes. A flexible feedstock concept has been established for the industrially relevant Corynebacterium glutamicum, which naturally synthesizes the yellow C50 carotenoid decaprenoxanthin. In this study, we aimed to use a preprocessed aquaculture sidestream for production of carotenoids, including the fish feed ingredient astaxanthin by C. glutamicum. The addition of a preprocessed aquaculture sidestream to the culture medium did not inhibit growth, obviated the need for addition of several components of the mineral salt’s medium, and notably enhanced production of astaxanthin by an engineered C. glutamicum producer strain. Improved astaxanthin production was scaled to 2 L bioreactor fermentations. This strategy to improve astaxanthin production was shown to be transferable to production of several native and non-native carotenoids. Thus, this study provides a proof-of-principle for improving carotenoid production by C. glutamicum upon supplementation of a preprocessed aquaculture sidestream. Moreover, in the case of astaxanthin production it may be a potential component of a circular economy in aquaculture. Full article
(This article belongs to the Section Green Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p><b>Carotenoid Biosynthesis in <span class="html-italic">C. glutamicum</span>.</b> Gene names are given next to the reactions catalyzed by their gene products. Heterologous genes are depicted with a grey box. GAP: Glyceraldehyde 3-phosphate; IPP: isopenthenyl pyrophosphate; DMAPP: dimethylallyl diphosphate; BABR: bisanhydrobacterioruberin; C.p.450: 2,2′-bis-(4-hydroxy-3-methybut-2enyl)-β,β-carotene; <span class="html-italic">dxs</span>: 1-deoxy-D-xylulose 5-phosphate synthase; <span class="html-italic">idsA</span>: geranylgeranyl pyrophosphate synthase; <span class="html-italic">crtE</span>: geranylgeranyl pyrophosphate synthase; <span class="html-italic">crtB</span>: phytoene synthase, <span class="html-italic">crtI</span>: phytoene desaturase; <span class="html-italic">crtEb</span>: lycopene elongase; <span class="html-italic">crtY<sub>e</sub></span><sub>/<span class="html-italic">f</span></sub>: ϵ-cyclase; <span class="html-italic">crtY<sub>g</sub></span><sub>/<span class="html-italic">h Ml</span></sub>: C50 carotenoid γ-cyclase from <span class="html-italic">Micrococcus leuteus</span>; <span class="html-italic">lbtBC<sub>Ds</sub></span>: subunit of C50 carotenoid β-cyclase (B) and lycopene elongase (C) from <span class="html-italic">Dietzia</span> sp. CQ4; <span class="html-italic">lbtAB<sub>Ds</sub></span>: C50 carotenoid β-cyclase from <span class="html-italic">Dietzia</span> sp. CQ4; <span class="html-italic">crtY<sub>Pa</sub></span>: lycopene cyclase from <span class="html-italic">Pantoea ananatis</span>; <span class="html-italic">crtW<sub>Fp</sub></span>: β-carotene ketolase from <span class="html-italic">Fulvimarina pelagi</span>; <span class="html-italic">crtZ<sub>Fp</sub></span>: β-carotene hydroxylase from <span class="html-italic">Fulvimarina pelagi</span>.</p>
Full article ">Figure 2
<p><b>Nutrient composition of the aquaculture sidestream.</b> Macro- and Micro-nutrients detected in an analysis of the untreated aquaculture sidestream performed by Eurofins Agraranalytik Deutschland GmbH. Nutrients below the detection limit are not represented.</p>
Full article ">Figure 3
<p><b>Growth of <span class="html-italic">C. glutamicum</span> WT in AQ containing media.</b> ∆OD<sub>600 nm</sub>, µ<sub>max,</sub> and decaprenoxanthin production after 48 h of <span class="html-italic">C. glutamicum</span> WT grown in a Biolector<sup>®</sup> flowerplate microcultivation system. The maximal OD<sub>600 nm</sub> difference from the initial OD<sub>600 nm</sub> during 48 h of cultivation is given as ∆OD<sub>600 nm</sub>. Values and error bars represent means and standard deviations of triplicate cultivations. Statistical significance in comparison to the cultivation in CGXII medium was assessed for ∆OD<sub>600 nm</sub> (marked in green) and decaprenoxanthin production (marked in black) in Student’s <span class="html-italic">t</span>-test (*** <span class="html-italic">p</span> &lt; 0.0001, ** <span class="html-italic">p</span> &lt; 0.001, * <span class="html-italic">p</span> &lt; 0.05). (<b>A</b>) Growth on CGXII, CGXII with addition of 20% (<span class="html-italic">v</span>/<span class="html-italic">v</span>) AQ and CGXII with 20% (<span class="html-italic">v</span>/<span class="html-italic">v</span>) AQ replacing media components of the CGXII composition. (<b>B</b>) Growth on CGXII without carbon source, 5 to 40% (<span class="html-italic">v</span>/<span class="html-italic">v</span>) AQ were supplemented as replacement. (<b>C</b>) Growth on AQ as the sole medium component, with adjustment to pH 7 and the addition of MOPS buffer, glucose, (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, and/or urea and phosphorous source (P). The last column represents the AQ based medium CGAQ.</p>
Full article ">Figure 4
<p><b>Carotenoid production of <span class="html-italic">C. glutamicum</span> strains in AQ supplemented media.</b> Carotenoid production of <span class="html-italic">C. glutamicum</span> MB001∆<span class="html-italic">crtR</span> (decaprenoxanthin), LYC6 (lycopene), CP1 (C.p.450), BABR1 (bisanhydrobacterioruberin), SAX1 (sarcinaxanthin), BETA4 (β-carotene), ZEA5 (zeaxanthin), CAN5 (canthaxanthin), ASTA* (astaxanthin) grown on CGXII, CGXII supplemented with 20% (<span class="html-italic">v</span>/<span class="html-italic">v</span>) AQ, or the AQ derived medium CGAQ for 48 h. Values and error bars represent means and standard deviations of triplicate cultivations. Statistical significance in comparison to the cultivation of each strain in CGXII medium was assessed in Student´s <span class="html-italic">t</span>-test (*** <span class="html-italic">p</span> &lt; 0.0001, ** <span class="html-italic">p</span> &lt; 0.001, * <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p><b>Batch-Fermentations.</b> Progression of astaxanthin content (red squares), OD<sub>600 nm</sub> (green dots), agitator speed (grey line), and relative dissolved oxygen concentration (rDOS) (blue line) over time during 2 L batch fermentations with <span class="html-italic">C. glutamicum</span> ASTA* grown in CGXII medium (<b>A</b>) and CGXII medium supplemented with 20% (<span class="html-italic">v</span>/<span class="html-italic">v</span>) AQ (<b>B</b>).</p>
Full article ">
17 pages, 4273 KiB  
Article
OAT3 Participates in Drug–Drug Interaction between Bentysrepinine and Entecavir through Interactions with M8—A Metabolite of Bentysrepinine—In Rats and Humans In Vitro
by Aijie Zhang, Fanlong Yang, Yang Yuan, Cai Li, Xiaokui Huo, Jing Liu, Shenzhi Zhou, Wei Li, Na Zhang, Jianfeng Liu, Shiqi Dong, Huirong Fan, Ying Peng and Jiang Zheng
Molecules 2023, 28(4), 1995; https://doi.org/10.3390/molecules28041995 - 20 Feb 2023
Cited by 4 | Viewed by 2045
Abstract
Bentysrepinine (Y101) is a novel phenylalanine dipeptide for the treatment of hepatitis B virus. Renal excretion played an important role in the elimination of Y101 and its metabolites, M8 and M9, in healthy Chinese subjects, although the molecular mechanisms of renal excretion and [...] Read more.
Bentysrepinine (Y101) is a novel phenylalanine dipeptide for the treatment of hepatitis B virus. Renal excretion played an important role in the elimination of Y101 and its metabolites, M8 and M9, in healthy Chinese subjects, although the molecular mechanisms of renal excretion and potential drug–drug interactions (DDIs) remain unclear. The present study aimed to determine the organic anion transporters (OATs) involved in the renal disposition of Y101 and to predict the potential DDI between Y101 and entecavir, the first-line agent against HBV and a substrate of OAT1/3. Pharmacokinetic studies and uptake assays using rat kidney slices, as well as hOAT1/3-HEK293 cells, were performed to evaluate potential DDI. The co-administration of probenecid (an inhibitor of OATs) significantly increased the plasma concentrations and area under the plasma concentration–time curves of M8 and M9 but not Y101, while reduced renal clearance and the cumulative urinary excretion of M8 were observed in rats. The time course of Y101 and M8 uptake via rat kidney slices was temperature-dependent. Moreover, the uptake of M8 was inhibited significantly by probenecid and benzylpenicillin, but not by p-aminohippurate or tetraethyl ammonium. M8 was found to be a substrate of hOAT3, but Y101 is not a substrate of either hOAT1 or hOAT3. Additionally, the entecavir inhibited the uptake of M8 in the hOAT3-transfected cells and rat kidney slices in vitro. Interestingly, no significant changes were observed in the pharmacokinetic parameters of Y101, M8 or entecavir, regardless of intravenous or oral co-administration of Y101 and entecavir in rats. In conclusion, M8 is a substrate of OAT3 in rats and humans. Furthermore, M8 also mediates the DDI between Y101 and entecavir in vitro, mediated by OAT3. We speculate that it would be safe to use Y101 with entecavir in clinical practice. Our results provide useful information with which to predict the DDIs between Y101 and other drugs that act as substrates of OAT3. Full article
(This article belongs to the Special Issue New Advances in Drug Metabolism and Pharmacokinetics)
Show Figures

Figure 1

Figure 1
<p>Mean plasma concentration–time curves of Y101 (<b>A</b>), M8 (<b>B</b>) and M9 (<b>C</b>) after intravenous administration of Y101 (25 mg/kg) or Y101 + PRO (100 mg/kg). Data are expressed as mean ± SD (* <span class="html-italic">p</span> &lt; 0.05 vs. Y101 group; <span class="html-italic">n</span> = 3).</p>
Full article ">Figure 2
<p>Cumulative urine-excretion curves of Y101 (<b>A</b>), M8 (<b>B</b>) and M9 (<b>C</b>) and the renal clearances of Y101 and its metabolites (<b>D</b>) after intravenous administration of Y101 (25 mg/kg), Y101 + PRO (100 mg/kg) and Y101 + ETV (0.06 mg/kg). Data are expressed as mean ± SD (* <span class="html-italic">p</span> &lt; 0.05 vs. Y101 group; <span class="html-italic">n</span> = 6).</p>
Full article ">Figure 3
<p>Mean plasma concentration–time curves of ETV (<b>A</b>), Y101 (<b>B</b>), M8 (<b>C</b>) and M9 (<b>D</b>) after intravenous administration of Y101 (25 mg/kg) and Y101 + ETV (0.06 mg/kg). Data are expressed as mean ± SD (* <span class="html-italic">p</span> &lt; 0.05 vs. Y101 group; <span class="html-italic">n</span> = 4).</p>
Full article ">Figure 4
<p>Mean plasma concentration–time curves of ETV (<b>A</b>), Y101 (<b>B</b>), M8 (<b>C</b>) and M9 (<b>D</b>) after oral administration of Y101 (60 mg/kg) and Y101 + ETV (0.06 mg/kg). Data are expressed as mean ± SD (* <span class="html-italic">p</span> &lt; 0.05 vs. Y101 group; <span class="html-italic">n</span> = 4).</p>
Full article ">Figure 5
<p>Cumulative urine-excretion curves of ETV (<b>A</b>) and the renal clearance of ETV (<b>B</b>) after intravenous administration of Y101 (25 mg/kg) and Y101 + ETV (0.06 mg/kg). Data are expressed as mean ± SD (* <span class="html-italic">p</span> &lt; 0.05 vs. ETV group; <span class="html-italic">n</span> = 6).</p>
Full article ">Figure 6
<p>Time-dependent and temperature-dependent uptake of Y101 (2.0 µM, (<b>A</b>)), M8 (5.0 µM, (<b>B</b>)) and M9 (1.0 µM, (<b>C</b>)) in kidney slices. The concentration of PRO was 100 µM. (*, <span class="html-italic">p</span> ˂ 0.05; **, <span class="html-italic">p</span> ˂ 0.01). Data are expressed as mean ± SD, <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 7
<p>Effects of OATs inhibitors and substrates on the uptake of Y101 (2.0 µM, (<b>A</b>)) and M8 (5.0 µM, (<b>B</b>)) in kidney slices (*, <span class="html-italic">p</span> ˂ 0.05; **, <span class="html-italic">p</span> ˂ 0.01 vs. control). Data are expressed as mean ± SD, <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 8
<p>Time-dependent uptake of ETV (10 µM, (<b>A</b>)), Y101 (2.0 µM, (<b>B</b>)) and M8 (5.0 µM, (<b>C</b>)) in kidney slices (*, <span class="html-italic">p</span> ˂ 0.05). Data are expressed as mean ± SD, <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 9
<p>Uptake of Y101, M8, PAH and ES in OAT1/3-HEK293 cells. (<b>A</b>): uptake of Y101 (2.0 µM) in mock, hOAT1 and hOAT3-HEK293 cells; (<b>B</b>): uptake of M8 (10 µM) in mock and hOAT1-HEK293 cells in the absence or presence of PRO; (<b>C</b>): uptake of M8 (10 µM) in mock and hOAT3-HEK293 cells in the absence or presence of PRO (**, <span class="html-italic">p</span> ˂ 0.01 vs. M8 alone); (<b>D</b>): uptake of PAH (10 µM) and ES (10 µM) with or without PRO (100 µM) for 10 min (*, <span class="html-italic">p</span> ˂ 0.05 vs. mock cells; <sup>#</sup>, <span class="html-italic">p</span> ˂ 0.05 vs. without-PRO group). Data are expressed as mean ± SD, <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 10
<p>Concentration-dependent profile (<b>A</b>) and Eadie–Hofstee plot (<b>B</b>) for the uptake of M8 in mock and hOAT3-HEK293 cells. Uptakes of M8 in mock and hOAT3-HEK293 cells were measured at concentrations between 2 and 1000 µM. Data are expressed as mean ± SD, <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 11
<p>The DDI between Y101 (2.0 µM), M8 (10 µM) and ETV (10 µM) in hOAT1 (<b>B</b>) and hOAT3-HEK293 cells (<b>A</b>,<b>C</b>). *, <span class="html-italic">p</span> ˂ 0.05 vs. M8-alone group. Data are expressed as mean ± SD, <span class="html-italic">n</span> = 3.</p>
Full article ">Scheme 1
<p>Proposed biotransformation pathways of Y101 in humans.</p>
Full article ">
12 pages, 1892 KiB  
Communication
Low-Coordinate Mixed Ligand NacNac Complexes of Rare Earth Metals
by Svetlana V. Klementyeva, Taisiya S. Sukhikh, Pavel A. Abramov and Andrey I. Poddel’sky
Molecules 2023, 28(4), 1994; https://doi.org/10.3390/molecules28041994 - 20 Feb 2023
Cited by 3 | Viewed by 2611
Abstract
We report the synthesis and characterization of two types of new mixed-ligand rare earth complexes: tetracoordinate (NacNacMes)Ln(BIANdipp) (Ln = Dy (1), Er (2) and Y (3)) and pentacoordinate (NacNacMes)Ln(APdipp)(THF) [...] Read more.
We report the synthesis and characterization of two types of new mixed-ligand rare earth complexes: tetracoordinate (NacNacMes)Ln(BIANdipp) (Ln = Dy (1), Er (2) and Y (3)) and pentacoordinate (NacNacMes)Ln(APdipp)(THF) (Ln = Dy (4), Er (5) and Y (6)). The first three compounds were prepared by the reaction of [(BIANDipp)LnI] with potassium β-diketiminate. The salt metathesis of β-diketiminato-supported rare earth dichlorides (NacNacMes)LnCl2(THF)2 with sodium o-amidophenolate results in compounds 46. The crystal structures of complexes 16 were determined by single-crystal analysis. The combination of bulky monoanionic N-mesityl-substituted β-diketiminates with sterically hindered redox-active ligands led to the very low coordination numbers of rare earths and strong distortion of the chelate ligands. Full article
(This article belongs to the Special Issue Molecules in 2023)
Show Figures

Figure 1

Figure 1
<p>The molecular structures of dysprosium (<b>1</b>), erbium (<b>2</b>), and yttrium (<b>3</b>) complexes of the type (NacNac<sup>Mes</sup>)Ln (BIAN<sup>dipp</sup>). The ellipsoids of 50% probability. The hydrogen atoms are hidden.</p>
Full article ">Figure 2
<p>The molecular structures of dysprosium (<b>4</b>), erbium (<b>5</b>), and yttrium (<b>6</b>) complexes of the type (NacNac<sup>Mes</sup>)Ln(AP<sup>dipp</sup>)(THF). The ellipsoids of 50% probability. The hydrogen atoms are hidden.</p>
Full article ">Scheme 1
<p>Synthesis of complexes (NacNac<sup>Mes</sup>)Ln(BIAN<sup>dipp</sup>) <b>1</b>–<b>3</b>.</p>
Full article ">Scheme 2
<p>Synthesis of complexes (NacNac<sup>Mes</sup>)Ln(AP<sup>dipp</sup>)(THF) <b>4</b>–<b>6</b>.</p>
Full article ">
17 pages, 4520 KiB  
Article
Flow-Based Fmoc-SPPS Preparation and SAR Study of Cathelicidin-PY Reveals Selective Antimicrobial Activity
by Shama Dissanayake, Junming He, Sung H. Yang, Margaret A. Brimble, Paul W. R. Harris and Alan J. Cameron
Molecules 2023, 28(4), 1993; https://doi.org/10.3390/molecules28041993 - 20 Feb 2023
Cited by 6 | Viewed by 3158
Abstract
Antimicrobial peptides (AMPs) hold promise as novel therapeutics in the fight against multi-drug-resistant pathogens. Cathelicidin-PY (NH2-RKCNFLCKLKEKLRTVITSHIDKVLRPQG-COOH) is a 29-residue disulfide-cyclised antimicrobial peptide secreted as an innate host defence mechanism by the frog Paa yunnanensis (PY) and reported to possess broad-spectrum antibacterial [...] Read more.
Antimicrobial peptides (AMPs) hold promise as novel therapeutics in the fight against multi-drug-resistant pathogens. Cathelicidin-PY (NH2-RKCNFLCKLKEKLRTVITSHIDKVLRPQG-COOH) is a 29-residue disulfide-cyclised antimicrobial peptide secreted as an innate host defence mechanism by the frog Paa yunnanensis (PY) and reported to possess broad-spectrum antibacterial and antifungal properties, exhibiting low cytotoxic and low hemolytic activity. Herein, we detail the total synthesis of cathelicidin-PY using an entirely on-resin synthesis, including assembly of the linear sequence by rapid flow Fmoc-SPPS and iodine-mediated disulfide bridge formation. By optimising a synthetic strategy to prepare cathelicidin-PY, this strategy was subsequently adapted to prepare a bicyclic head-to-tail cyclised derivative of cathelicidin-PY. The structure-activity relationship (SAR) of cathelicidin-PY with respect to the N-terminally positioned disulfide was further probed by preparing an alanine-substituted linear analogue and a series of lactam-bridged peptidomimetics implementing side chain to side chain cyclisation. The analogues were investigated for antimicrobial activity, secondary structure by circular dichroism (CD), and stability in human serum. Surprisingly, the disulfide bridge emerged as non-essential to antimicrobial activity and secondary structure but was amenable to synthetic modification. Furthermore, the synthetic AMP and multiple analogues demonstrated selective activity towards Gram-negative pathogen E. coli in physiologically relevant concentrations of divalent cations. Full article
(This article belongs to the Special Issue Advances in Research of Short Peptides II)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Sequence alignment of recently discovered amphibian cathelicidins, mature peptides shown. Blue denotes cationic residues and pink denotes the cysteine residues forming a disulfide bond.</p>
Full article ">Figure 2
<p>Structure of the cathelicidin-PY peptide, <b>1</b>, and a series of analogues, <b>2–9</b> of cathelicidin-PY. Dab = 2,4-diaminobutyric acid.</p>
Full article ">Figure 3
<p>RP-HPLC chromatograms (214 nm) monitoring key intermediates during on-resin preparation of linear cathelicidin-PY (<b>12</b>) under microwave irradiation according to <a href="#molecules-28-01993-sch001" class="html-scheme">Scheme 1</a>a. (<b>a</b>) confirms the desired product Fmoc-protected linear cathelicidin-PY<sup>20−29</sup> (t<sub>R</sub> = 21.5 min) (<b>b</b>) confirms the desired product Fmoc-protected linear cathelicidin-PY<sup>10−29</sup> (t<sub>R</sub> = 18.6 min) (<b>c</b>) the desired product, linear cathelicidin-PY (<b>12</b>), was not present (<b>d</b>) confirms the presence of the desired linear cathelicidin-PY (<b>12</b>) (t<sub>R</sub> = 18.5 min) under automated synthetic conditions according to <a href="#molecules-28-01993-sch001" class="html-scheme">Scheme 1</a>b.</p>
Full article ">Figure 4
<p>Circular dichroism (CD) spectra carried out in water for cathelicidin−PY and associated analogues, <b>2</b>, <b>3</b>, and <b>8</b>, depicting a random coil conformation. CD spectra were collected at 25 °C with peptides dissolved at 0.2 mM in pH 7.4 phosphate buffer (20 mM).</p>
Full article ">Figure 5
<p>Circular dichroism (CD) spectra carried out in membrane-mimetic environments (TFE:H<sub>2</sub>O, 1:1, <span class="html-italic">v</span>/<span class="html-italic">v</span>) for cathelicidin−PY and associated analogues, <b>2</b>, <b>3</b>, and <b>8</b>, depicting an α−helical secondary structure. CD spectra were collected at 25 °C with peptides dissolved at 0.2 mM.</p>
Full article ">Scheme 1
<p>Synthesis of linear cathelicidin-PY peptide using (<b>a</b>) Microwave irradiation (<b>b</b>) Tribute automated synthesiser; AM-PS-aminomethyl polystyrene resin, DIC-<span class="html-italic">N,N’</span>-diisopropylcarbodiimide, HCTU-O-(1H-6-chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, HMPP linker-3-(4-hydroxymethylphenoxy)propionic acid, NMM-<span class="html-italic">N</span>-methylmorpholine, TFA-trifluoroacetic acid, DODT-2,2-(ethylenedioxy)diethanethiol, TIS-triisopropylsilane.</p>
Full article ">Scheme 2
<p>Synthesis of linear cathelicidin-PY on automated synthesiser using different resin substitutions (<b>a</b>) TentaGel HL NH<sub>2</sub> (0.48 mmolg<sup>−1</sup>) and (<b>b</b>) TentaGel S NH<sub>2</sub> (0.26 mmolg<sup>−1</sup>); 6-Cl-HOBt-1-hydroxy-6-chloro-benzotriazole, DIC-<span class="html-italic">N,N’</span>-diisopropylcarbodiimide, DMAP-4-methyldiaminopyridine, DODT-2,2-(Ethylenedioxy)diethanethiol NMM-<span class="html-italic">N</span>-methylmorpholine, PyAOP-7-azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate, TFA-trifluoroacetic acid, TIS-triisopropylsilane.</p>
Full article ">Scheme 3
<p>Synthesis of linear cathelicidin-PY on continuous flow synthesis at 65 °C with a flow rate of 15 mL/min and a resonance time of 40 s using different resin substitutions (<b>a</b>) ChemMatrix (0.6 mmolg<sup>−1</sup>) and (<b>b</b>) TentaGel S NH<sub>2</sub> (0.25 mmolg<sup>−1</sup>); 6-Cl-HOBt-1-hydroxy-6-chloro-benzotriazole, HATU-hexafluorophosphate azabenzotriazole tetramethyl uronium, DIC-<span class="html-italic">N,N’</span>-diisopropylcarbodiimide, DMAP-4-methyldiaminopyridine, DODT-2,2 - (ethylenedioxy)diethanethiol, NMM-<span class="html-italic">N</span>-methylmorpholine, PyAOP-7-azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate, FA-formic acid, TFA-trifluoroacetic acid, TIS-triisopropylsilane.</p>
Full article ">Scheme 4
<p>(<b>a</b>) On-resin iodine-mediated disulfide bond formation to afford cathelicidin-PY (<b>1</b>) prepared by flow-based Fmoc-SPPS in accordance with <a href="#molecules-28-01993-sch003" class="html-scheme">Scheme 3</a>b; (<b>b</b>) RP-HPLC (214 nm) reaction monitoring.</p>
Full article ">Scheme 5
<p>Synthesis of bicyclic cathelicidin-PY analogue <b>3</b> on continuous flow synthesis at 65 °C with a flow rate of 15 mL/min and a resonance time of 40 s. 6-Cl-HOBt-1-hydroxy-6-chloro-benzotriazole, DIC-<span class="html-italic">N,N’</span>-diisopropylcarbodiimide, DIPEA-<span class="html-italic">N,N</span>-diisopropylethylamine, DMAP-4-dimethylaminopyridine, FA-formic acid, HATU-hexafluorophosphate azabenzotriazole tetramethyl uronium, HFIP-1,1,1,3,3,3, hexafluoro-2-propanol, NMM-<span class="html-italic">N</span>-methylmorpholine, PyAOP-7-azabenzotriazol-1-yloxy)tripyrrolidinophosphonium, hexafluorophosphate, TFA-trifluoroacetic acid, TIS-triisopropylsilane.</p>
Full article ">Scheme 6
<p>Synthesis of cathelicidin-PY peptidomimetics (<b>4–9</b>) at 65 °C with a flow rate of 15 mL/min and a resonance time of 40 s; 6-Cl-HOBt-1-hydroxy-6-chloro-benzotriazole, Dab = 2,4-diaminobutyric acid, Dde-1- (4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl, DIC-<span class="html-italic">N,N’</span>-diisopropylcarbodiimide, DIPEA-<span class="html-italic">N,N</span>-diisopropylethylamine, DMAP-4-methyldiaminopyridine, FA-formic acid, HATU-hexafluorophosphate azabenzotriazole tetramethyl uronium, NMM-<span class="html-italic">N</span>-methylmorpholine, Mtt-4-methyltrityl, <span class="html-italic">O</span>-2-PhiPr-2-phenylisopropyl, PyAOP-7-azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate, TFA-trifluoroacetic acid, TIS-triisopropylsilane.</p>
Full article ">
18 pages, 4616 KiB  
Article
Impact of Sample Preparation Methods on Single-Cell X-ray Microscopy and Light Elemental Analysis Evaluated by Combined Low Energy X-ray Fluorescence, STXM and AFM
by Lucia Merolle, Lorella Pascolo, Luisa Zupin, Pietro Parisse, Valentina Bonanni, Gianluca Gariani, Sasa Kenig, Diana E. Bedolla, Sergio Crovella, Giuseppe Ricci, Stefano Iotti, Emil Malucelli, George Kourousias and Alessandra Gianoncelli
Molecules 2023, 28(4), 1992; https://doi.org/10.3390/molecules28041992 - 20 Feb 2023
Cited by 5 | Viewed by 2534
Abstract
Background: Although X-ray fluorescence microscopy is becoming a widely used technique for single-cell analysis, sample preparation for this microscopy remains one of the main challenges in obtaining optimal conditions for the measurements in the X-ray regime. The information available to researchers on sample [...] Read more.
Background: Although X-ray fluorescence microscopy is becoming a widely used technique for single-cell analysis, sample preparation for this microscopy remains one of the main challenges in obtaining optimal conditions for the measurements in the X-ray regime. The information available to researchers on sample treatment is inadequate and unclear, sometimes leading to wasted time and jeopardizing the experiment’s success. Many cell fixation methods have been described, but none of them have been systematically tested and declared the most suitable for synchrotron X-ray microscopy. Methods: The HEC-1-A endometrial cells, human spermatozoa, and human embryonic kidney (HEK-293) cells were fixed with organic solvents and cross-linking methods: 70% ethanol, 3.7%, and 2% paraformaldehyde; in addition, HEK-293 cells were subjected to methanol/ C3H6O treatment and cryofixation. Fixation methods were compared by coupling low-energy X-ray fluorescence with scanning transmission X-ray microscopy and atomic force microscopy. Results: Organic solvents lead to greater dehydration of cells, which has the most significant effect on the distribution and depletion of diffusion elements. Paraformaldehyde provides robust and reproducible data. Finally, the cryofixed cells provide the best morphology and element content results. Conclusion: Although cryofixation seems to be the most appropriate method as it allows for keeping cells closer to physiological conditions, it has some technical limitations. Paraformaldehyde, when used at the average concentration of 3.7%, is also an excellent alternative for X-ray microscopy. Full article
(This article belongs to the Special Issue Recent Advances and Future Trends in Sample Preparation II)
Show Figures

Figure 1

Figure 1
<p>Experimental plan of the experiment indicating the fixation protocols used for each type of sample. Paraformaldehyde (PFA); Ethanol (EtOH); Methanol (MeOH); Acetone (C<sub>3</sub>H<sub>6</sub>O).</p>
Full article ">Figure 2
<p>STXM and XRF analysis of the HEC-1-A cell line. Absorption (Abs) and differential phase contrast (PhC) images, alongside with O, Na, Mg, and Scattering maps of HEC-1A endometrial cells fixed with three different methods: (<b>a</b>) EtOH 70% (mapped area 60 × 52 µm<sup>2</sup>), (<b>b</b>) PFA 2% (mapped area 68 × 68 µm<sup>2</sup>), and (<b>c</b>) PFA 3.7% (mapped area 52 × 52 µm<sup>2</sup>). Scale bars are 10 µm. (<b>d</b>) Normalised average XRF counts of O, Na, and Mg in HEC-1-A adenocarcinoma endometrial cells fixed with EtOH 70%, PFA 2%, and 3.7% evaluated on at least 6 cells/fixation method. (<b>e</b>) Min-to-max box plot comparing oxygen MFC as obtained by descriptive statistical analysis used to determine the coefficient of variation. A two-way ANOVA with multiple comparisons test was performed to test the statistical difference among the fixation methods. *** <span class="html-italic">p</span> &lt; 0.001. The STXM images (Abs and PhC) and XRF images were acquired at 1500 eV excitation energy with a step size of 200 nm and 800 nm, respectively, and an acquisition time of 10 ms/pixel and 6 s/pixel, respectively.</p>
Full article ">Figure 3
<p>AFM images with corresponding surface profiles of the HEC-1A endometrial cells. The first column shows the same cells depicted in <a href="#molecules-28-01992-f002" class="html-fig">Figure 2</a>, fixed with different methods: (<b>a</b>) EtOH, (<b>b</b>) PFA 2%, and (<b>c</b>) PFA 3.7%. The other pictures of panels a-c show additional cells prepared with the same three fixation methods. (<b>d</b>) Min-to-max box plot of HEC-1-A cell volume (µm<sup>3</sup>).</p>
Full article ">Figure 4
<p>STXM and XRF analysis of human spermatozoa. Absorption (Abs) and phase contrast (PhC) images, together with O, Na and Mg maps of spermatozoa fixed with different methods: (<b>a</b>) EtOH 70% (mapped area 30 × 75 µm<sup>2</sup>), (<b>b</b>) PFA 2% (mapped area 70 × 70 µm<sup>2</sup>), and (<b>c</b>) PFA 3.7% (mapped area 70 × 70 µm<sup>2</sup>). Scale bars are 10 µm. (<b>d</b>) Normalised average XRF counts of O, Na, and Mg in spermatozoa fixed with EtOH 70%, PFA 2%, and 3.7% evaluated on at least 6–10 cells/patient/fixation method. (<b>e</b>) Min-to-max box plot comparing oxygen MFC as obtained by descriptive statistical analysis used to determine the coefficient of variation. A two-way ANOVA with multiple comparisons test was performed to test the statistical difference among the fixation methods. ** <span class="html-italic">p</span> &lt; 0.005. The STXM images (Abs and PhC) and XRF images were acquired at 1500 eV excitation energy with a step size of 400 nm and 1 μm, respectively, and an acquisition time of 5 ms/pixel and 10 s/pixel, respectively.</p>
Full article ">Figure 5
<p>AFM images of human spermatozoa fixed with different methods: (<b>a</b>) EtOH, (<b>b</b>) PFA 2%, and (<b>c</b>) PFA 3.7%. Scale bar is 10 µm. (<b>d</b>) Spermatozoa cell volume data expressed as a min-to-max box plot. A one-way ANOVA with multiple comparisons test was performed to test the statistical difference among the mean volumes obtained after fixations. ** <span class="html-italic">p</span> &lt; 0.005 * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 6
<p>STXM and XRF analysis of HEK-293 cells. Absorption (Abs) and phase contrast (PhC) images, together with O, Na, Mg, and Scattering maps of HEK-293 cells fixed with different methods: (<b>a</b>) EtOH 70% (mapped area 45 × 45 µm<sup>2</sup>), (<b>b</b>) PFA 2% (mapped area 34 × 34 µm<sup>2</sup>), (<b>c</b>) PFA 3.7% (mapped area 25 × 30 µm<sup>2</sup>), (<b>d</b>) 1:1 MeOH/C<sub>3</sub>H<sub>6</sub>O (mapped area 40 × 40 µm<sup>2</sup>), and (<b>e</b>) cryofixed (mapped area 50 × 50 µm<sup>2</sup>). Scale bars are 10 µm. (<b>f</b>) Normalised average X-ray fluorescence counts of O, Na, and Mg in HEK-293. A two-way ANOVA with multiple comparisons test was performed on at least on 4 cells/fixation method to test the statistical difference among the fixation methods. * <span class="html-italic">p</span> &lt; 0.05, **** <span class="html-italic">p</span> &lt; 0.0005. (<b>g</b>) Min-to-max box plot comparing oxygen MFC as obtained by descriptive statistical analysis used to determine the coefficient of variation. The STXM images (Abs and PhC) and XRF images were acquired at 1500 eV excitation energy with a step size of 500 nm and an acquisition time of 33 ms/pixel and 6 s/pixel, respectively.</p>
Full article ">Figure 7
<p>AFM images with corresponding surface profiles collected on a selection of HEK-293 cells fixed with the different methods: (<b>a</b>) EtOH 70%, (<b>b</b>) PFA 2%, (<b>c</b>) PFA 3.7%, (<b>d</b>) 1:1 MeOH/C<sub>3</sub>H<sub>6</sub>O, and (<b>e</b>) cryofixed. Scale bar is 5 µm. Cell volume calculated from the AFM images collected on a selection of HEK-293 cells fixed with ethanol and PFA 3.7% and compared with the rest of the applied fixation methods (<b>f</b>). The second column shows the same cells depicted in <a href="#molecules-28-01992-f006" class="html-fig">Figure 6</a> (where a, b and e are rotated of 90 degrees left, 90 degrees right and 180 degrees respectively compared to <a href="#molecules-28-01992-f006" class="html-fig">Figure 6</a>), while the other columns depict additional cells prepared with the same five fixation methods. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.005, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0005.</p>
Full article ">
19 pages, 5104 KiB  
Review
Recent Progress in Vacuum Engineering of Ionic Liquids
by Yuji Matsumoto
Molecules 2023, 28(4), 1991; https://doi.org/10.3390/molecules28041991 - 20 Feb 2023
Cited by 1 | Viewed by 2391
Abstract
Since the discovery of ionic liquids (ILs) as a new class of liquid that can survive in a vacuum at room temperature, they have been aimed at being characterized with vacuum analysis techniques and used in vacuum processes for the last two decades. [...] Read more.
Since the discovery of ionic liquids (ILs) as a new class of liquid that can survive in a vacuum at room temperature, they have been aimed at being characterized with vacuum analysis techniques and used in vacuum processes for the last two decades. In this review, our state-of-the-art of the vacuum engineering of ILs will be introduced. Beginning with nanoscale vacuum deposition of IL films and their thickness-dependent ionic conductivity, there are presented some new applications of the ellipsometry to in situ monitoring of the thickness of IL films and their glass transitions, and of the surface thermal fluctuation spectroscopy to investigation of the rheological properties of IL films. Furthermore, IL-VLS (vapor-liquid-solid) growth, a vacuum deposition via IL, has been found successful, enhancing the crystallinity of vacuum-deposited crystals and films, and sometimes controlling their surface morphology and polymorphs. Among recent applications of ILs are the use of metal ions-containing IL and thin film nano IL gel. The former is proposed as a low temperature evaporation source of metals, such as Ta, in vacuum deposition, while the latter is demonstrated to work as a gate electrolyte in an electric double layer organic transistor. Full article
(This article belongs to the Special Issue Properties and Applications of Ionic Liquids-Based Advanced Materials)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Schematic of an IR laser deposition system equipped with an ellipsometry for thickness monitoring. (<b>b</b>) Time-development of the IL [emim][TFSA] film thickness estimated by ellipsometry and the QCM mass signal, both of which values are linearly well correlated. Reproduced with permission from ref. [<a href="#B19-molecules-28-01991" class="html-bibr">19</a>]. Copyright 2020, IOP Publishing Ltd.</p>
Full article ">Figure 2
<p>(<b>a</b>) IR absorption spectra of [omim][TFSA] IL films with different thicknesses. (<b>b</b>) Linear increase in the peak intensity of the absorption band at around 1350 cm<sup>−1</sup> attributed to the SO<sub>2</sub> vibration mode of TFSA anions with the film thickness between 10 nm and 1000 nm (note that 1000 nm-thick IL film was prepared by spin coating). Reproduced with permission from ref. [<a href="#B20-molecules-28-01991" class="html-bibr">20</a>]. Copyright 2018, The Chemical Society of Japan.</p>
Full article ">Figure 3
<p>SEM and tapping-mode AFM topographic images, along with their line profiles of [bmim][PF<sub>6</sub>] on a sapphire(0001) substrate (<b>a</b>,<b>b</b>) and [omim][TFSA] on a Si(100) substrate (<b>c</b>,<b>d</b>). Reproduced with permission from ref. [<a href="#B18-molecules-28-01991" class="html-bibr">18</a>]. Copyright 2011, American Chemical Society.</p>
Full article ">Figure 4
<p>(<b>a</b>) Molecular structures of two imidazolium-based ILs with an octyl side chain on the cation ring, [omim][TFSA] and [omim][PF<sub>6</sub>]. (<b>b</b>) Temperature dependences of ε for a Nb:TiO<sub>2</sub>(110) substrate (upper panel) and a 60 nm-thick [omim][TFSA] film (lower panel). (<b>c</b>) The plot of the glass transition temperature <span class="html-italic">T</span><sub>g</sub> of [omim][TFSA] films for different thicknesses. The green, blue and black lines indicate the bulk <span class="html-italic">T</span><sub>g</sub> values reported for comparison. Reproduced with permission from ref. [<a href="#B23-molecules-28-01991" class="html-bibr">23</a>]. Copyright 2020, Elsevier.</p>
Full article ">Figure 5
<p>(<b>a</b>) Schematic of the bi-layer structure. (<b>b</b>) Series of the plots of ε against the temperature for the [omim][PF<sub>6</sub>]/[omim][TFSA] bi-layer films. (<b>c</b>) <span class="html-italic">T</span><sub>g</sub> plotted as a function of [omim][PF<sub>6</sub>] weight fraction for [omim][PF<sub>6</sub>]/[omim][TFSA] thin films (closed circle), [omim] [PF<sub>6</sub>]-[omim][TFSA] bulk mixtures (open circle) and literature (open squares, [<a href="#B24-molecules-28-01991" class="html-bibr">24</a>,<a href="#B25-molecules-28-01991" class="html-bibr">25</a>,<a href="#B26-molecules-28-01991" class="html-bibr">26</a>]). The dashed line is a linear correlation between <span class="html-italic">T</span><sub>g</sub> and the [omim][PF<sub>6</sub>] weight fraction predicted from the Fox equation using the measured <span class="html-italic">T</span><sub>g</sub> values of [omim][PF<sub>6</sub>] and [omim][TFSA] bulk ILs (this work). Reproduced with permission from ref. [<a href="#B23-molecules-28-01991" class="html-bibr">23</a>]. Copyright 2020, Elsevier.</p>
Full article ">Figure 6
<p>(<b>a</b>) Molecular dynamics calculations of thin film IL [emim][TFSA] for various thicknesses in contact with a solid substrate of sapphire. (<b>b</b>) The thickness dependence of ionic conductivity for IL thin films experimentally obtained (red filled circle), together with the simulated result by the molecular dynamics calculation (blue open circle). The dashed black line is the bulk conductivity [<a href="#B31-molecules-28-01991" class="html-bibr">31</a>]. Reproduced with permission from ref. [<a href="#B29-molecules-28-01991" class="html-bibr">29</a>]. Copyright 2018, American Chemical Society.</p>
Full article ">Figure 7
<p>(<b>a</b>) Ionic conductivity of Li[TFSA]-[emim][TFSA] solution films, along with two possible solution models with the Li[TFSA] content exceeding the bulk solubility limit. Reproduced with permission from ref. [<a href="#B19-molecules-28-01991" class="html-bibr">19</a>]. Copyright 2020, IOP Publishing Ltd. (<b>b</b>) Temperature dependence of the ionic conductivity of a [N<sub>1112</sub>][TFSA] IL film, along with its chemical structure. Reproduced with permission from ref. [<a href="#B33-molecules-28-01991" class="html-bibr">33</a>]. Copyright 2019, Elsevier.</p>
Full article ">Figure 8
<p>(<b>a</b>) Schematic of the principle of surface thermal fluctuation spectroscopy. (<b>b</b>–<b>d</b>) Surface thermal fluctuation spectra for 300-nm-, 2.5 nm- and 1.5 nm-thick IL [emim][TFSA] films. The solid red line is the experimental result and the dashed blue line and the solid black line are the fitting results based on the simple Newtonian liquid model and a modified model with the inclusion of viscoelasticity, respectively. Reproduced with permission from ref. [<a href="#B36-molecules-28-01991" class="html-bibr">36</a>]. Copyright 2021, IOP Publishing Ltd.</p>
Full article ">Figure 9
<p>Schematic of the vapor-liquid-solid (VLS) process.</p>
Full article ">Figure 10
<p>The out-of-plane XRD pattern (<b>a</b>) and optical microscope image (<b>b</b>) of an IL-VLS grown KBr(111) film on an α-Al<sub>2</sub>O<sub>3</sub>(0001) substrate. Reproduced with permission from ref. [<a href="#B30-molecules-28-01991" class="html-bibr">30</a>]. Copyright 2016, The Royal Society of Chemistry. (<b>c</b>) FM-AFM topographic image of the KBr(111) film observed in [bmim][PF<sub>6</sub>] IL, together with the line profile along the c-d red line. (<b>d</b>) Δ<span class="html-italic">f</span> (frequency shift) versus tip-to-sample distance curve obtained on the KBr film in [bmim][PF<sub>6</sub>] IL by FM-AFM measurement. Reproduced with permission from ref. [<a href="#B56-molecules-28-01991" class="html-bibr">56</a>]. Copyright 2022, IOP Publishing Ltd.</p>
Full article ">Figure 11
<p>(<b>a</b>) Molecular structure of 3T. (<b>b</b>) Optical microscope image of an IL-VLS grown 3T crystals using an IL [emim][TFSA], along with a set of polarized optical microscope images of one piece of the crystals before and after a 45 degree-sample rotation. (<b>c</b>) XRD patterns of 3T samples IL-VLS grown for different thick IL films. (<b>d</b>) Plots of the relative peak area intensities of the LT 006 and HT 003 reflections, which are both normalized by the peak area intensity of α-Al<sub>2</sub>O<sub>3</sub> 0006 reflection, as a function of the IL thickness. Reproduced with permission from ref. [<a href="#B60-molecules-28-01991" class="html-bibr">60</a>]. Copyright 2019, IOP Publishing Ltd.</p>
Full article ">Figure 12
<p>(<b>a</b>) XRF intensity ratio of Ta(Lα)/P(Kα) for the deposit plotted against that of the corresponding original IL solution. (<b>b</b>) XPS spectra of an IL deposit of the Ta ions-containing IL solution (1.7 × 10<sup>−1</sup> M) on SiOx/Si(001) before and after the air-annealing treatment. (<b>c</b>) SEM image of the air-annealed sample of the IL deposit. (<b>d</b>) EDX elemental mapping of O, Si, P and Ta in the SEM. Reproduced with permission from ref. [<a href="#B66-molecules-28-01991" class="html-bibr">66</a>]. Copyright 2022, IOP Publishing Ltd.</p>
Full article ">Figure 13
<p>Schematic of the process for fabricating IL gel films.</p>
Full article ">Figure 14
<p>(<b>a</b>) IR absorption spectra of the urea films after vacuum annealing at different temperatures. (<b>b</b>) AFM image of a porous polyurea film via IL [emim][TFSA]. Reproduced with permission from ref. [<a href="#B69-molecules-28-01991" class="html-bibr">69</a>]. Copyright 2018, Elsevier. (<b>c</b>) Ion conduction behavior of an IL gel film, which was synthesized by the vacuum annealing (60 °C) of a 20 nm-thick bilayer consisting of 1:1 thickness ratio of urea and IL [emim][TFSA] films. (<b>d</b>) EDL transistor action of pentacene with a several tens nm-thick IL gel film as a gate electrolyte. Reproduced with permission from ref. [<a href="#B70-molecules-28-01991" class="html-bibr">70</a>]. Copyright 2020, American Chemical Society.</p>
Full article ">
19 pages, 700 KiB  
Review
Renoprotective Effects of Tanshinone IIA: A Literature Review
by Zhengtao Chen, Haoyue Feng, Chuan Peng, Zehua Zhang, Qianghua Yuan, Hong Gao, Shiyun Tang and Chunguang Xie
Molecules 2023, 28(4), 1990; https://doi.org/10.3390/molecules28041990 - 20 Feb 2023
Cited by 15 | Viewed by 3784
Abstract
The kidney is an important organ in the human body, with functions such as urine production, the excretion of metabolic waste, the regulation of water, electrolyte and acid–base balance and endocrine release. The morbidity and mortality of kidney diseases are increasing year by [...] Read more.
The kidney is an important organ in the human body, with functions such as urine production, the excretion of metabolic waste, the regulation of water, electrolyte and acid–base balance and endocrine release. The morbidity and mortality of kidney diseases are increasing year by year worldwide, and they have become a serious public health problem. In recent years, natural products derived from fungi, plants and animals have become an important alternative source of treatment for kidney diseases because of their multiple pathways, multiple targets, safety, low toxicity and few side effects. Tanshinone IIA (Tan IIA) is a lipid-soluble diterpene quinone isolated from the Chinese herb Salvia miltiorrhiza, considered as a common drug for the treatment of cardiovascular diseases. As researchers around the world continue to explore its unknown biological activities, it has also been found to have a wide range of biological effects, such as anti-cancer, anti-oxidative stress, anti-inflammatory, anti-fibrotic, and hepatoprotective effects, among others. In recent years, many studies have elaborated on its renoprotective effects in various renal diseases, including diabetic nephropathy (DN), renal fibrosis (RF), uric acid nephropathy (UAN), renal cell carcinoma (RCC) and drug-induced kidney injury caused by cisplatin, vancomycin and acetaminophen (APAP). These effects imply that Tan IIA may be a promising drug to use against renal diseases. This article provides a comprehensive review of the pharmacological mechanisms of Tan IIA in the treatment of various renal diseases, and it provides some references for further research and clinical application of Tan IIA in renal diseases. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p><span class="html-italic">Salvia miltiorrhiza</span>, Tan IIA and STS. (<b>A</b>) is the picture of <span class="html-italic">salvia miltiorrhiza</span>; (<b>B</b>) is tanshinone IIA; (<b>C</b>) is STS.</p>
Full article ">Figure 2
<p>Pharmacological role of Tan IIA in the treatment of kidney disease.</p>
Full article ">
16 pages, 15552 KiB  
Article
Chemical Profiling, Bioactive Properties, and Anticancer and Antimicrobial Potential of Juglans regia L. Leaves
by Natalia Żurek, Karolina Pycia, Agata Pawłowska, Leszek Potocki and Ireneusz Tomasz Kapusta
Molecules 2023, 28(4), 1989; https://doi.org/10.3390/molecules28041989 - 20 Feb 2023
Cited by 15 | Viewed by 2934
Abstract
The aim of this study was to assess the biological potential of the polyphenolic fraction isolated from J. regia leaves, collected in the Subcarpathian region (Poland). The phenolic profile was determined using the UPLC-PDA-MS/MS method. Biological activity was determined by evaluating the antioxidant, [...] Read more.
The aim of this study was to assess the biological potential of the polyphenolic fraction isolated from J. regia leaves, collected in the Subcarpathian region (Poland). The phenolic profile was determined using the UPLC-PDA-MS/MS method. Biological activity was determined by evaluating the antioxidant, anticancer, antibacterial, and antifungal effects. Prior to this study, the purified polyphenolic fraction was not been tested in this regard. A total of 40 phenolic compounds (104.28 mg/g dw) were identified, with quercetin 3-O-glucoside and quercetin pentosides dominating. The preparation was characterized by a high ability to chelate iron ions and capture O2•− and OH radicals (reaching IC50 values of 388.61, 67.78 and 193.29 µg/mL, respectively). As for the anticancer activity, among the six tested cell lines, the preparation reduced the viability of the DLD-1, Caco-2, and MCF-7 lines the most, while in the antibacterial activity, among the seven tested strains, the highest susceptibility has been demonstrated against K. pneumoniae, S. pyogenes, and S. aureus. Depending on the needs, such a preparation can be widely used in the design of functional food and/or the cosmetics industry. Full article
Show Figures

Figure 1

Figure 1
<p>Effect of preparation of <span class="html-italic">J. regia</span> leaves on the cell viability of CCD 841 CoN, DLD-1, Caco-2, MCF-7, U87MG, U251MG, and SK-Mel-29. The cells were treated extracts in five concentrations (10–750 µg/mL) for 24, 48 and 72 h. The number of viable control (non-treated) cells at each time point served as 100%. Graphs represent mean values ± SD. Asterisks indicate a statistically significant differences (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001) among samples according to Student’s <span class="html-italic">t</span>-test.</p>
Full article ">Figure 2
<p>(<b>A</b>) Water and ethanolic <span class="html-italic">J. regia</span> extracts-mediated changes on microbial growth: G (−) <span class="html-italic">Escherichia coli</span> PCM2209, <span class="html-italic">Klebsiella pneumoniae</span> DSM 30104, <span class="html-italic">Pseudomonas aeruginosa</span> DSM 19880; G (+) <span class="html-italic">Staphylococcus aureus</span> DSM 104437, <span class="html-italic">Streptococcus pyogenes</span> PCM 2318, and <span class="html-italic">Enterococcus faecalis</span>; <span class="html-italic">Candida albicans</span> ATCC14053. The tested microorganisms were treated with <span class="html-italic">J. regia</span> leaves extracts at 10 mg/mL, 1 mg/mL, 0.1 mg/mL surface spotted onto the indicator lawn—NA agar (bacteria) and YPD agar (<span class="html-italic">Candida</span>) media. Representative micrographs of bacterial and yeast culture dishes; (<b>B</b>) diameter of growth inhibition (halo) of bacteria induced by walnut extracts; (<b>a</b>) 10 mg/mL water extract; (<b>b</b>) 10 mg/mL alcoholic extract; (<b>c</b>) 1 mg/mL alcoholic extract. The values are expressed as means ± SD. Letters indicate a statistically significant differences (capital letter &lt; 0.01, small letter &lt; 0.001) among samples according to ANOVA and HSD Tukey’s.</p>
Full article ">
17 pages, 4211 KiB  
Article
Manipulation in Culture Conditions of Nanofrustulum shiloi for Enhanced Fucoxanthin Production and Isolation by Preparative Chromatography
by Ayşegül Erdoğan, Ayça Büşra Karataş, Dilan Demir, Zeliha Demirel, Merve Aktürk, Öykü Çopur and Meltem Conk-Dalay
Molecules 2023, 28(4), 1988; https://doi.org/10.3390/molecules28041988 - 20 Feb 2023
Cited by 5 | Viewed by 2502
Abstract
Microalgae produce a variety of high-value chemicals including carotenoids. Fucoxanthin is also a carotenoid that has many physiological functions and biological properties. For this reason, the cost-effective production of fucoxanthin at an industrial scale has gained significant attention. In the proposed study, fucoxanthin [...] Read more.
Microalgae produce a variety of high-value chemicals including carotenoids. Fucoxanthin is also a carotenoid that has many physiological functions and biological properties. For this reason, the cost-effective production of fucoxanthin at an industrial scale has gained significant attention. In the proposed study, fucoxanthin production was aimed to be increased by altering the culture conditions of N. shiloi. The effect of light intensity aeration rate, different nitrogen sources, and oxidative stress on the biomass and fucoxanthin productivity have been discussed. Based on these results, the fucoxanthin increased to 97.45 ± 2.64 mg/g by adjusting the light intensity to 50 µmol/m2s, and aeration rate at 5 L/min using oxidative stress through the addition of 0.1 mM H2O2 and 0.1 mM NaOCl to the culture medium. Fucoxanthin was then purified with preparative HPLC using C30 carotenoid column (10 mm × 250 mm, 5 μm). After the purification procedure, Liquid chromatography tandem mass spectrometry (LC–MS/MS) and UV-vis spectroscopy were employed for the confirmation of fucoxanthin. This study presented a protocol for obtaining and purifying considerable amounts of biomass and fucoxanthin from diatom by manipulating culture conditions. With the developed methodology, N. shiloi could be evaluated as a promising source of fucoxanthin at the industrial scale for food, feed, cosmetic, and pharmaceutical industries. Full article
(This article belongs to the Section Analytical Chemistry)
Show Figures

Figure 1

Figure 1
<p>Plot showing the effect of light intensities and aeration rates on the optical density of <span class="html-italic">N. shiloi</span>. Reported results are the average of three replicates (i.e., n = 3), with error bars denoting one standard deviation about the mean.</p>
Full article ">Figure 2
<p>Plot showing the effect of different nitrogen sources on the optical density of <span class="html-italic">N. shiloi</span>. Reported results are the average of three replicates (i.e., n = 3), with error bars denoting one standard deviation about the mean.</p>
Full article ">Figure 3
<p>Plot showing the effect of various oxidative stress conditions on the optical density of <span class="html-italic">N. shiloi</span>. Reported results are the average of three replicates (i.e., n = 3), with error bars denoting one standard deviation about the mean.</p>
Full article ">Figure 4
<p>Morphological changes of <span class="html-italic">N. shiloi</span> in response to different light intensities (<b>a</b>) N<sub>5-50</sub> (<b>b</b>) N<sub>5-300</sub> and (<b>c</b>) N<sub>5-150</sub>.</p>
Full article ">Figure 5
<p>Morphological changes of <span class="html-italic">N. shiloi</span> in response to different nitrogen sources (<b>a</b>) NaNO<sub>3</sub> and (<b>b</b>) CH<sub>4</sub>N<sub>2</sub>O.</p>
Full article ">Figure 6
<p>Morphological changes of <span class="html-italic">N. shiloi</span> in response to oxidative stress (<b>a</b>) no <sup>.</sup>OH and <sup>1</sup>O<sub>2</sub> (<b>b</b>) 0.1 mM H<sub>2</sub>O<sub>2</sub> + 0.1 mM NaOCl.</p>
Full article ">Figure 7
<p>Prep-HPLC chromatogram for <span class="html-italic">N. shiloi</span> extract obtained at 450 nm.</p>
Full article ">Figure 8
<p>UV-vis spectra of purified fucoxanthin form <span class="html-italic">N. shiloi</span>.</p>
Full article ">Figure 9
<p>Liquid chromatography mass spectrometric data for fucoxanthin (<b>a</b>) LC chromatogram and (<b>b</b>) LC–MS/MS spectra for fucoxanthin purified from <span class="html-italic">N. shiloi</span> after preparative chromatography.</p>
Full article ">
16 pages, 2477 KiB  
Article
Design, Synthesis, and Pharmacology of New Triazole-Containing Quinolinones as CNS Active Agents
by Wennan Zhao, Mingxia Song, Yi Hua, Yangnv Zhu, Wenli Liu, Qishan Xia, Xianqing Deng and Yushan Huang
Molecules 2023, 28(4), 1987; https://doi.org/10.3390/molecules28041987 - 20 Feb 2023
Cited by 1 | Viewed by 2227
Abstract
Epilepsy and major depressive disorder are the two of the most common central nervous system (CNS) diseases. Clinicians and patients call for new antidepressants, antiseizure medicines, and in particular drugs for depression and epilepsy comorbidities. In this work, a dozen new triazole-quinolinones were [...] Read more.
Epilepsy and major depressive disorder are the two of the most common central nervous system (CNS) diseases. Clinicians and patients call for new antidepressants, antiseizure medicines, and in particular drugs for depression and epilepsy comorbidities. In this work, a dozen new triazole-quinolinones were designed, synthesized, and investigated as CNS active agents. All compounds reduced the immobility time significantly during the forced swim test (FST) in mice at the dosage of 50 mg/kg. Compounds 3f3j gave superior performance over fluoxetine in the FST with more reductions of the immobility time. Compound 3g also reduced immobility time significantly in a tail suspension test (TST) at the dosage of 50 mg/kg, though its anti-immobility activity was inferior to that of fluoxetine. An open field test was carried out and it eliminated the false-positive possibility of 3g in the FST and TST, which complementarily supported the antidepressant activity of 3g. We also found that almost all compounds except 3k exhibited antiseizure activity in the maximal electroshock seizure (MES) model at 100 or 300 mg/kg. Compounds 3c, 3f, and 3g displayed the ED50 of 63.4, 78.9, and 84.9 mg/kg, and TD50 of 264.1, 253.5, and 439.9 mg/kg, respectively. ELISA assays proved that the mechanism for the antiseizure and antidepressant activities of compound 3g was via affecting the concentration of GABA in mice brain. The molecular docking study showed a good interaction between 3g and the amino acid residue of the GABAA receptor. Excellent drug-like properties and pharmacokinetic properties of compound 3al were also predicted by Discovery Studio. These findings provided a new skeleton to develop agents for the treatment of epilepsy and depression comorbidities. Full article
Show Figures

Figure 1

Figure 1
<p>The modification of the leads to the targets (<b>3a</b>–<b>l</b>).</p>
Full article ">Figure 2
<p>Effects of compounds <b>3a</b>–<b>l</b> and FXT (i.p., 50 mg/kg) on the duration of immobility time in the FST. Ten animals were used for each group. * <span class="html-italic">p</span> &lt; 0.05 compared to the control group, ** <span class="html-italic">p</span> &lt; 0.01 compared to the control group, *** <span class="html-italic">p</span> &lt; 0.001 compared to the control group.</p>
Full article ">Figure 3
<p>Effects of compound <b>3g</b> and FXT (i.p., 10 mg/kg and 25 mg/kg) on the duration of immobility time in the FST at lower dosages. Ten animals were used for each group. ** <span class="html-italic">p</span> &lt; 0.01 compared to the control group, *** <span class="html-italic">p</span> &lt; 0.001 compared to the control group, **** <span class="html-italic">p</span> &lt; 0.001 compared to the control group.</p>
Full article ">Figure 4
<p>Effects of compound <b>3g</b> and FXT (i.p., 50 mg/kg) on the duration of immobility time in the TST. Ten animals were used for each group. ** <span class="html-italic">p</span> &lt; 0.01 compared to the control group, *** <span class="html-italic">p</span> &lt; 0.001 compared to the control group.</p>
Full article ">Figure 5
<p>Effects of single treatment with <b>3g</b> (50 mg/kg) on the exploratory behaviors in the open-field test. Locomotion indicates the number of line crossings; rearing indicates the number of times seen standing on hind legs; grooming indicates the number of modifications. Ten animals were used for each group.</p>
Full article ">Figure 6
<p>Effects of <b>3g</b>, phenytoin, and FXT on whole brain GABA (<b>A</b>) and 5-HT (<b>B</b>) levels in mice brains. Eight animals were used for each group. * <span class="html-italic">p</span> &lt; 0.05 compared to the control group, ** <span class="html-italic">p</span> &lt; 0.01 compared to the control group.</p>
Full article ">Figure 7
<p>Effects of compound <b>3g</b> (50 mg/kg) on the immobility time in the TSC-treated mice in the FST. Eight animals were used for each group. ** <span class="html-italic">p</span> &lt; 0.01 compared to the vehicle group; <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared to the vehicle + <b>3g</b> group.</p>
Full article ">Figure 8
<p>Interactions between compound <b>3g</b> (green), diazepam (red), and amino acid residues at the active site of the GABA<sub>A</sub> receptor.</p>
Full article ">Figure 9
<p>The overlying pattern of compound <b>3g</b> (green), and diazepam (red) in the binding pocket of the GABA<sub>A</sub> receptor.</p>
Full article ">Figure 10
<p>Prediction of ADME/T properties for compounds <b>3a</b>–<b>l</b>.</p>
Full article ">Scheme 1
<p>The synthetic route of target compounds <b>3a</b>–<b>l</b>.</p>
Full article ">
28 pages, 4608 KiB  
Article
Surface Properties of Graffiti Coatings on Sensitive Surfaces Concerning Their Removal with Formulations Based on the Amino-Acid-Type Surfactants
by Marcin Bartman, Sebastian Balicki, Lucyna Hołysz and Kazimiera A. Wilk
Molecules 2023, 28(4), 1986; https://doi.org/10.3390/molecules28041986 - 20 Feb 2023
Cited by 3 | Viewed by 2413
Abstract
Water-in-oil (w/o) nanoemulsions stabilized with amino acid surfactants (AAS) are one example of nanotechnology detergents of the “brush on, wipe off”-type for removing graffiti coatings from different sensitive surfaces. The high-pressure homogenization (HPH) process was used to obtain the nanostructured fluids (NSFs), including [...] Read more.
Water-in-oil (w/o) nanoemulsions stabilized with amino acid surfactants (AAS) are one example of nanotechnology detergents of the “brush on, wipe off”-type for removing graffiti coatings from different sensitive surfaces. The high-pressure homogenization (HPH) process was used to obtain the nanostructured fluids (NSFs), including the non-toxic and eco-friendly components such as AAS, esterified vegetable oils, and ethyl lactate. The most effective NSF detergent was determined by response surface methodology (RSM) optimization. Afterwards, several surface properties, i.e., topography, wettability, surface free energy, and the work of water adhesion to surfaces before and after their coverage with the black graffiti paint, as well as after the removal of the paint layers by the eco-remover, were determined. It was found that the removal of graffiti with the use of the NSF detergent is more dependent on the energetic properties and microporous structure of the paint coatings than on the properties of the substrates on which the layers were deposited. The use of NSFs and knowledge of the surface properties could enable the development of versatile detergents that would remove unwanted contamination from various surfaces easily and in a controlled way. Full article
(This article belongs to the Special Issue Surfactants and Interfaces)
Show Figures

Figure 1

Figure 1
<p>Changes in the key parameters (DH and TSI) to characterize the stability of nanoemulsions during the 3-month storage period. (<bold>A</bold>) NE No. 7. (<bold>B</bold>) NE No. 10. (<bold>C</bold>) NE No. 11.</p>
Full article ">Figure 2
<p>Photographs of the reference sensitive surfaces available on the commercial market (<bold>A</bold>). Images of the reference sensitive surfaces at 40× magnification (<bold>B</bold>).</p>
Full article ">Figure 3
<p>Optical profilometer images of 0.94 × 1.3 mm<sup>2</sup> surface areas of <bold>A</bold>—glass (G), <bold>B</bold>—aluminum (Al), <bold>C</bold>—stone (S), <bold>D</bold>—marble (M), 1—bare surface sample, 2—surface covered with paint, 3—surface after removal paint coating with NE No. 10 removal, and 4—bare surface after cleaning with NE No. 10.</p>
Full article ">Figure 4
<p>Roughness height distribution on the surfaces of glass (<bold>A</bold>), aluminum (<bold>B</bold>), stone (<bold>C</bold>) and marble (<bold>D</bold>) of the dimensions of 0.94 × 1.3 mm<sup>2</sup>.</p>
Full article ">Figure 5
<p>Surface roughness profiles of the running band on the bare stone (S-B), covered with the paint (S-B-P) after its removal and cleaning the bare surface (S-B-Pc). The figure also shows the values of the roughness parameters along the profile curve.</p>
Full article ">Figure 6
<p>Advancing and receding contact angles of water on the bare sensitive surfaces, covered with paint, after the removal of the paint coating with NE No. 10, and after cleaning the bare surface with NE No. 10. (<bold>A</bold>) Surfaces from the man-made materials. (<bold>B</bold>) Surfaces from the natural materials.</p>
Full article ">Figure 7
<p>Surface free energy calculated from the CAH approach of bare sensitive surfaces, covered with the paint (B-P), after its removal (B-Pc), and cleaning the bare surfaces with NE No. 10 (Bc). (<bold>A</bold>) The surfaces produced from the man-made materials. (<bold>B</bold>) The surfaces produced from the natural materials.</p>
Full article ">Figure 8
<p>Work of adhesion of water to the bare sensitive surface samples, covered with paint (B-P), after paint removal (B-Pc), and cleaning bare surfaces with NE No. 10 (Bc). (<bold>A</bold>) The surfaces produced from man-made materials. (<bold>B</bold>) The surfaces produced from natural materials.</p>
Full article ">Figure 9
<p>Dynamic contact angles of nanoemulsion No. 10 versus the time contact with the paint covered (<bold>A</bold>) and bare sensitive surfaces (<bold>B</bold>) and its work of spreading on the paint covered (<bold>C</bold>) and bare sensitive surfaces (<bold>D</bold>).</p>
Full article ">
17 pages, 21551 KiB  
Article
Elucidating Flavonoid and Antioxidant Activity in Edible and Medicinal Herbs Woodwardia japonica (L.f.) Sm. Based on HPLC-ESI-TOF-MS and Artificial Neural Network Model: Response to Climatic Factors
by Xin Wang, Jianguo Cao, Lin Tian, Baodong Liu, Yawen Fan and Quanxi Wang
Molecules 2023, 28(4), 1985; https://doi.org/10.3390/molecules28041985 - 20 Feb 2023
Viewed by 2025
Abstract
Woodwardia japonica is a kind of great potential edible and medicinal fern. In a previous study, it was found that flavonoid and antioxidant activity of W. japonica from different sites were different. However, the cause of the differences has still been unclear, which [...] Read more.
Woodwardia japonica is a kind of great potential edible and medicinal fern. In a previous study, it was found that flavonoid and antioxidant activity of W. japonica from different sites were different. However, the cause of the differences has still been unclear, which has restricted the utilization of W. japonica. In this paper, flavonoid and antioxidant activity of W. japonica from nine different regions were determined with the method of a colorimetric assay with UV-VIS spectrophotometry and HPLC-ESI-TOF-MS, and the effects of climate factors on flavonoids and antioxidant activities were evaluated by mathematical modeling and statistical methods. The results showed: (1) total flavonoid content (TFC) of W. japonica from Wuyi Mountain (Jiangxi) was the highest, which might be related to the low temperature; (2) the differences of antioxidant activities of W. japonica might be related to precipitation; (3) five flavonols, two flavones and one isoflavone were tentatively identified in W. japonica; (4) flavonol and isoflavone might be affected by sunshine duration, and flavones were probably related to temperature. In conclusion, the effects of climate factors on flavonoids and antioxidants are significant, which would provide an important basis for further exploring the mechanism of climate affecting secondary metabolites. Full article
(This article belongs to the Special Issue Analyses and Applications of Phenolic Compounds in Food)
Show Figures

Figure 1

Figure 1
<p>TFCs of <span class="html-italic">Woodwardia japonica</span> from different districts (mg/g) (<span class="html-italic">w</span>/<span class="html-italic">w</span>).</p>
Full article ">Figure 2
<p>IC<sub>50</sub> (including scavenging activities of DPPH, ABTS, O<sub>2</sub><sup>−</sup>) and reducing force on Fe<sup>3+</sup> of <span class="html-italic">W. japonica</span>.</p>
Full article ">Figure 3
<p>Flavonoids of <span class="html-italic">W. japonica</span> from different habitats (Sample sites shown in <a href="#app1-molecules-28-01985" class="html-app">Table S1, in Supplementary Materials</a>).</p>
Full article ">Figure 4
<p>Response of total flavonoid content to climate factors based on the Artificial Neural Network Model. AT: Average temperature per month; MAT: Maximum temperature per month; MIT: minimum temperature per month; AP: Average precipitation per month; DP: Daytime precipitation per month; OP: Overnight precipitation per month; SD: Sunshine duration per month; ARH: Average relative humidity per month.</p>
Full article ">Figure 5
<p>Response of antioxidant activity to climate factors.</p>
Full article ">Figure 6
<p>The correlation coefficient matrix between TFC, antioxidant activity of <span class="html-italic">W. japonica</span> and climate factors.</p>
Full article ">Figure 7
<p>Dendrogram and heatmap of hierarchical cluster analysis of climate factors, TFC and antioxidant activity among nine main producing areas of <span class="html-italic">W. japonica.</span> Concentrations are illustrated by a color gradient from blue (high) to red (low).</p>
Full article ">Figure 8
<p>Compound 1–8: isotrifolin, rutin, myricetin deoxyhexoside, quercetin-3-rutinoside, luteolin 6-C-glucoside, quercitrin, genestein G2, luteolin-4′-<span class="html-italic">O</span>-(6″-trans-caffeoyl)-β-<span class="html-small-caps">d</span>-glucopyranoside.</p>
Full article ">Figure 9
<p>PCA score plots using flavonoid types with different climate factors (<span class="html-italic">n</span> = 3). 1–8: isotrifolin, rutin, myricetin deoxyhexoside, quercetin-3-rutinoside, luteolin 6-C-glucoside, quercitrin, genestein G2, luteolin-4′-<span class="html-italic">O</span>-(6″-trans-caffeoyl)-β-<span class="html-small-caps">d</span>-glucopyranoside. The blue arrows refer to different climate factors.</p>
Full article ">Figure 10
<p>Dendrogram and heatmap of hierarchical cluster analysis of climate factors among eight flavonoids of <span class="html-italic">W. japonica.</span> Concentrations are illustrated by a color gradient from blue (high) to red (low). Compound 1–8: isotrifolin, rutin, myricetin deoxyhexoside, quercetin-3-rutinoside, luteolin 6-C-glucoside, quercitrin, genestein G2, luteolin-4′-<span class="html-italic">O</span>-(6″-trans-caffeoyl)-β-<span class="html-small-caps">d</span>-glucopyranoside.</p>
Full article ">Figure 11
<p>Morphological characteristics of <span class="html-italic">W. japonica</span>.</p>
Full article ">Figure 12
<p>The distribution of nine main producing areas of <span class="html-italic">W. japonica</span>.</p>
Full article ">
15 pages, 2079 KiB  
Article
Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors
by Marco J. Rotter, Sabrina Zentgraf, Lilia Weizel, Denia Frank, Luisa D. Burgers, Steffen Brunst, Robert Fürst, Anna Proschak, Thomas A. Wichelhaus and Ewgenij Proschak
Molecules 2023, 28(4), 1984; https://doi.org/10.3390/molecules28041984 - 20 Feb 2023
Cited by 3 | Viewed by 2567
Abstract
Metallo beta lactamases (MBLs) are among the most problematic resistance mechanisms of multidrug-resistant Gram-negative pathogens due to their broad substrate spectrum and lack of approved inhibitors. In this study, we propose the integration of catechol substructures into the design of thiol-based MBL inhibitors, [...] Read more.
Metallo beta lactamases (MBLs) are among the most problematic resistance mechanisms of multidrug-resistant Gram-negative pathogens due to their broad substrate spectrum and lack of approved inhibitors. In this study, we propose the integration of catechol substructures into the design of thiol-based MBL inhibitors, aiming at mimicking bacterial siderophores for the active uptake by the iron acquisition system of bacteria. We synthesised two catechol-containing MBL inhibitors, as well as their dimethoxy counterparts, and tested them for in vitro inhibitory activity against NDM-1, VIM-1, and IMP-7. We demonstrated that the most potent catechol-containing MBL inhibitor is able to bind Fe3+ ions. Finally, we could show that this compound restores the antibiotic activity of imipenem in NDM-1-expressing K. pneumoniae, while leaving HUVEC cells completely unaffected. Thus, siderophore-containing MBL inhibitors might be a valuable strategy to overcome bacterial MBL-mediated resistance to beta lactam antibiotics. Full article
Show Figures

Figure 1

Figure 1
<p>Upper line: most advanced MBL inhibitors. Middle line: approved thiol-containing drugs shown to inhibit MBLs. Bottom line: Approved sideromycin cifederocol.</p>
Full article ">Figure 2
<p>Design strategy of siderophore-containing MBL inhibitors. (<b>A</b>). X-ray structure of NDM-1 in complex with compound <b>1</b> (PDB code 6LJ0). Yellow and blue arrows indicate the positions which are sterically and chemically accessible for introduction of larger moieties. (<b>B</b>). Yellow and blue arrows indicate chemically tractable positions to introduce catechol moieties in compound <b>1</b>, which results in the design of compounds <b>2</b> and <b>3</b>.</p>
Full article ">Figure 3
<p>Evaluation of compounds <b>2</b>, <b>3</b>, <b>12</b>, and <b>18</b> in cytotoxicity assays. * Staurosporine (Stsp) was used as cytotoxic control.</p>
Full article ">Figure 4
<p>Binding of compound <b>3</b> to Fe<sup>3+</sup>. (<b>A</b>). ITC measurement of the binding event. FeCl<sub>3</sub> solution was titrated to the solution of compound <b>3</b>. (<b>B</b>). Model fit of the <b>3</b>:Fe<sup>3+</sup> binding. (<b>C</b>). Model structure of two molecules of 3 (orange and purple sticks) binding to Fe<sup>3+</sup> ion (cyan sphere).</p>
Full article ">Figure 5
<p>Proposed binding mode of compound <b>3</b> to NDM-1. Starting from the X-ray structure of compound <b>1</b> in complex with NDM-1 (PDB code 6LJ0), the catechol moiety was introduced manually and the complex was subsequently energy minimised.</p>
Full article ">Scheme 1
<p>(a) Meldrum´s acid, AcOH, i-PrOH/EtOAc, 75 °C, 3 h; (b) NaBH<sub>4</sub>, AcOH, DCM, 0 °C–r.t., 2.25 h; (c) Eschenmoser´s salt, MeOH, 70 °C, 18 h; (d) NaOH, 100 °C, 1 h, µw; (e) 1. SOCl<sub>2</sub>, DCM/DMF, 50 °C, 3 h, 2. <span class="html-italic">t</span>-Butyl-(2R)-2-piperidinecarboxylate 19, DIPEA, DCE/DMF, 90 °C, 1 h, µw; (f) Thioacetic acid, rt, 66 h; (g) TFA, DCM, 50 °C, o.n.; (h) NH<sub>3</sub> (25%), H<sub>2</sub>O, 0 °C–rt, 2.5 h; and (i) BBr<sub>3</sub>, DCM, −78 °C–r.t., o.n.</p>
Full article ">Scheme 2
<p>(a) 1. SOCl<sub>2</sub>, 90 °C, 2 h, 2. (<span class="html-italic">R</span>)-1-Boc-piperazine-2-carboxylic acid, DCM/pyridine/DMF, r.t., 20 h; (b) Benzyl bromide, KHCO<sub>3</sub>, 65 °C, 18 h; (c) HCl, DCM, r.t., o.n.; (d) 1. <span class="html-italic">D</span>-(-)-3-Acetylthio-2-methylpropionic acid, SOCl<sub>2</sub>, DCM/DMF, 0 °C–rt, o.n., 2. DIPEA, DCM, r.t., 18.5 h; (e) LiOH, H<sub>2</sub>O/THF, r.t., 4 h; and (f) BBr<sub>3</sub>, DCM, −78 °C–r.t., o.n.</p>
Full article ">
23 pages, 3305 KiB  
Article
Multicomponent Domino Cyclization of Ethyl Trifluoropyruvate with Methyl Ketones and Amino Alcohols as A New Way to γ-Lactam Annulated Oxazacycles
by Marina V. Goryaeva, Olesya A. Fefelova, Yanina V. Burgart, Marina A. Ezhikova, Mikhail I. Kodess, Pavel A. Slepukhin, Vasily S. Gaviko and Victor I. Saloutin
Molecules 2023, 28(4), 1983; https://doi.org/10.3390/molecules28041983 - 20 Feb 2023
Cited by 1 | Viewed by 1804
Abstract
A new route to bicyclic γ-lactams was found, which was proposed as a three-component cyclization of ethyl trifluoropyruvate with methyl ketones and 1,2-, 1,3-amino alcohols. As a result, a series of trifluoromethyl-substituted tetrahydropyrrolo [2,1-b]oxazol-5-ones and tetrahydropyrrolo[2,1-b][1,3]oxazine-6-ones was synthesized, in [...] Read more.
A new route to bicyclic γ-lactams was found, which was proposed as a three-component cyclization of ethyl trifluoropyruvate with methyl ketones and 1,2-, 1,3-amino alcohols. As a result, a series of trifluoromethyl-substituted tetrahydropyrrolo [2,1-b]oxazol-5-ones and tetrahydropyrrolo[2,1-b][1,3]oxazine-6-ones was synthesized, in which the substituent at the nodal carbon atom was varied. The introduction of a twofold excess of ethyl trifluoropyruvate in reactions with amino alcohols and acetone made it possible to obtain the same bicycles, but functionalized with a hydroxyester fragment, which are formed due to four-component interactions of the reagents. Transformations with 2-butanone and aminoethanol lead predominantly to similar bicycles, while an analogous reaction with aminopropanol gives N-hydroxypropyl-2,3-dihydropyrrol-5-one. Almost all bicycles are formed as two diastereomers, the structure of which was determined using 1H, 19F, 13C NMR spectroscopy, including two-dimensional experiments and XRD analysis. A domino mechanism for the formation of tetrahydropyrrolo[2,1-b]oxazacycles was proposed, which was confirmed by their stepwise synthesis through the preliminary preparation of the aldol and bis-aldol from ethyl trifluoropyruvate and methyl ketones. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Examples of bioactive γ-lactams.</p>
Full article ">Figure 2
<p>Diastereomeric structure of heterocycles <b>4</b>, <b>5</b> and <b>8</b>.</p>
Full article ">Figure 3
<p>The ORTEP view of compounds <b>4d<sup>c</sup></b> (<b>a</b>) and <b>8c<sup>c</sup></b> (<b>b</b>) according to XRD data.</p>
Full article ">Figure 4
<p>(<b>a</b>) The ORTEP view of compounds <b>5<sup>tc</sup></b> according to XRD data; (<b>b</b>) crystal packing of compounds <b>5<sup>tc</sup></b> with indication of intermolecular hydrogen bonds.</p>
Full article ">Figure 5
<p>Diastereomeric structure of dihydropyrrol-5-ones <b>11</b>.</p>
Full article ">Figure 6
<p>(<b>a</b>) The ORTEP view of compounds <b>11b</b> according to XRD data; (<b>b</b>) crystal packing of <b>11b</b> with indication of intermolecular hydrogen bonds.</p>
Full article ">Scheme 1
<p>Three-component reaction of ethyl trifluoropyruvate <b>1</b>, acetone <b>2a</b> and aminoethanol <b>3a</b>.</p>
Full article ">Scheme 2
<p>Three-component equimolar reactions of ethyl trifluoropyruvate <b>1</b> and methyl ketones <b>2a–d</b> with amino alcohols <b>3a,b</b> (all yields are given for isolated products).</p>
Full article ">Scheme 3
<p>Three-component reactions of a twofold excess of ethyl trifluoropyruvate <b>1</b> with acetone <b>2a</b> and amino alcohols <b>3a,b</b>.</p>
Full article ">Scheme 4
<p>Three-component reactions of a twofold excess of ethyl trifluoropyruvate <b>1</b> with 2-butanone <b>2b</b> and amino alcohols <b>3a,b</b>.</p>
Full article ">Scheme 5
<p>Three-component reactions of a twofold excess of ethyl trifluoropyruvate <b>1</b> with 2-hexanone <b>2c</b> and amino alcohols <b>3a,b</b>.</p>
Full article ">Scheme 6
<p>Two-step approach to obtaining products <b>4a,b</b> and <b>8a,b</b>.</p>
Full article ">Scheme 7
<p>Proposed pathways for the formation of heterocyclic aldols <b>5<sup>tc</sup>, 5<sup>cc</sup></b>.</p>
Full article ">Scheme 8
<p>Proposed mechanism of three- and four-component domino cyclization of ethyl trifluoropyruvate <b>1</b> with methyl ketones <b>2a–d</b> and amino alcohols <b>3a,b</b>.</p>
Full article ">
19 pages, 919 KiB  
Review
Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit
by Behrouz Mollashahi, Hamid Latifi-Navid, Iman Owliaee, Sara Shamdani, Georges Uzan, Saleh Jamehdor and Sina Naserian
Molecules 2023, 28(4), 1982; https://doi.org/10.3390/molecules28041982 - 20 Feb 2023
Cited by 7 | Viewed by 4753
Abstract
The most widely used genome editing toolkit is CRISPR (clustered regularly interspaced short palindromic repeats). It provides the possibility of replacing and modifying DNA and RNA nucleotides. Furthermore, with advancements in biological technology, inhibition and activation of the transcription of specific gene(s) has [...] Read more.
The most widely used genome editing toolkit is CRISPR (clustered regularly interspaced short palindromic repeats). It provides the possibility of replacing and modifying DNA and RNA nucleotides. Furthermore, with advancements in biological technology, inhibition and activation of the transcription of specific gene(s) has become possible. Bioinformatics tools that target the evolution of CRISPR-associated protein 9 (Cas9) turn this protein into a vehicle that is specific for a DNA or RNA region with single guide RNA (sgRNA). This toolkit could be used by researchers to investigate the function of stem cell gene(s). Here, in this review article, we cover recent developments and applications of this technique in stem cells for research and clinical purposes and discuss different CRISPR/Cas technologies for knock-out, knock-in, activation, or inhibition of gene expression. Additionally, a comparison of several deliveries and off-target detecting strategies is discussed. Full article
(This article belongs to the Section Molecular Structure)
Show Figures

Figure 1

Figure 1
<p>The zygote cell and its initial divisions (embryonic cells), which are considered totipotent stem cells, have the capacity to give rise to fully developed living organisms (body and placenta). Pluripotent stem cells, which can generate all cells that make up a live organism’s body following totipotent stem cells, are the next stage (mesoderm, endoderm, and ectoderm). Organoids are the new era for disease modeling, homeostasis, and development studies. Organoids derived from mesoderm, endoderm, and ectoderm are considered a new field of interest in biomedical research.</p>
Full article ">Figure 2
<p>CRISPR toolkit. (<b>A</b>). CRISPR technology was originally used to create double-strand breaks in eukaryotic DNA (with a bacterial origin (Streptococcus pyogenes)). 1. In bacteria, crRNA and tracrRNA guide Cas9 to target the intended region. These RNAs are artificially synthetized as a unique sgRNA to be more applicable in other creatures (yellow) 2. crRNA and tracrRNA are widely used in multiple experimental systems (e.g., mouse embryo microinjections, RNP electroporation into mammalian cell lines, etc.) [<a href="#B91-molecules-28-01982" class="html-bibr">91</a>,<a href="#B92-molecules-28-01982" class="html-bibr">92</a>] 3. Twenty nucleotides complementary to the target site are used to identify the target area (these nucleotides are designed in a targeted manner). 4. Before these 20 nucleotides, there are three PAM nucleotides (5′-NGG-3′ in Streptococcus pyogenes Cas9 system) which are necessary for CRISPR/Cas9 function. (<b>B</b>). 1. In order to modify the bases in a targeted way, the Cas9 protein was altered to cut only one strand of DNA by changing one amino acid in Cas9 protein (nickase Cas9 [nCas9]). 2. Additionally, they coupled the different base editor domains to the Cas9 protein. (<b>C</b>). 1. Prime editing, the subsequent iteration of this technique, cuts a DNA strand by creating a cut at the intended location. 2 and 3. The sgRNA is made in such a way that its 3′-end complements the two sides of cut site, and its 5′-end can recognize the target site. 4. The reverse transcriptase enzyme turns 3′ sgRNA into cDNA using this 3′ end as a primer. 5. In the cut region, bases are designed for knock-in to produce highly accurate results.</p>
Full article ">
30 pages, 4579 KiB  
Review
Quinones as Promising Compounds against Respiratory Viruses: A Review
by Ivan Chan-Zapata, Rocío Borges-Argáez and Guadalupe Ayora-Talavera
Molecules 2023, 28(4), 1981; https://doi.org/10.3390/molecules28041981 - 20 Feb 2023
Cited by 8 | Viewed by 3820
Abstract
Respiratory viruses represent a world public health problem, giving rise to annual seasonal epidemics and several pandemics caused by some of these viruses, including the COVID-19 pandemic caused by the novel SARS-CoV-2, which continues to date. Some antiviral drugs have been licensed for [...] Read more.
Respiratory viruses represent a world public health problem, giving rise to annual seasonal epidemics and several pandemics caused by some of these viruses, including the COVID-19 pandemic caused by the novel SARS-CoV-2, which continues to date. Some antiviral drugs have been licensed for the treatment of influenza, but they cause side effects and lead to resistant viral strains. Likewise, aerosolized ribavirin is the only drug approved for the therapy of infections by the respiratory syncytial virus, but it possesses various limitations. On the other hand, no specific drugs are licensed to treat other viral respiratory diseases. In this sense, natural products and their derivatives have appeared as promising alternatives in searching for new compounds with antiviral activity. Besides their chemical properties, quinones have demonstrated interesting biological activities, including activity against respiratory viruses. This review summarizes the activity against respiratory viruses and their molecular targets by the different types of quinones (both natural and synthetic). Thus, the present work offers a general overview of the importance of quinones as an option for the future pharmacological treatment of viral respiratory infections, subject to additional studies that support their effectiveness and safety. Full article
(This article belongs to the Collection Featured Reviews in Natural Products Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structures of antivirals against respiratory viruses.</p>
Full article ">Figure 2
<p>Chemical structures of the different types of quinones.</p>
Full article ">Figure 3
<p>Chemical structures of natural naphthoquinones <b>1</b>–<b>19</b>.</p>
Full article ">Figure 4
<p>Chemical structures of synthetic naphthoquinones <b>20</b>–<b>27</b>.</p>
Full article ">Figure 5
<p>Chemical structures of natural and synthetic anthraquinones <b>28</b>–<b>47</b>.</p>
Full article ">Figure 6
<p>Chemical structures of quinones <b>48</b>–<b>55</b>.</p>
Full article ">Figure 7
<p>Chemical structures of quinones <b>56</b>–<b>67</b>.</p>
Full article ">Figure 8
<p>Chemical structures of quinones <b>68</b>–<b>83</b>.</p>
Full article ">Figure 9
<p>Chemical structures of quinones <b>84</b>–<b>88</b>.</p>
Full article ">
20 pages, 4130 KiB  
Review
Advances on Hormones in Cosmetics: Illegal Addition Status, Sample Preparation, and Detection Technology
by Mengyue Li, Li Wang, Min Wang, Hua Zhao and Fengnian Zhao
Molecules 2023, 28(4), 1980; https://doi.org/10.3390/molecules28041980 - 20 Feb 2023
Cited by 5 | Viewed by 3173
Abstract
Owing to the rapid development of the cosmetic industry, cosmetic safety has become the focus of consumers’ attention. However, in order to achieve the desired effects in the short term, the illegal addition of hormones in cosmetics has emerged frequently, which could induce [...] Read more.
Owing to the rapid development of the cosmetic industry, cosmetic safety has become the focus of consumers’ attention. However, in order to achieve the desired effects in the short term, the illegal addition of hormones in cosmetics has emerged frequently, which could induce skin problems and even skin cancer after long-term use. Therefore, it is of great significance to master the illegal addition in cosmetics and effectively detect the hormones that may exist in cosmetics. In this review, we analyze the illegally added hormone types, detection values, and cosmetic types, as well as discuss the hormone risks in cosmetics for human beings, according to the data in unqualified cosmetics in China from 2017 to 2022. Results showed that although the frequency of adding hormones in cosmetics has declined, hormones are still the main prohibited substances in illegal cosmetics, especially facial masks. Because of the complex composition and the low concentration of hormones in cosmetics, it is necessary to combine efficient sample preparation technology with instrumental analysis. In order to give the readers a comprehensive overview of hormone analytical technologies in cosmetics, we summarize the advanced sample preparation techniques and commonly used detection techniques of hormones in cosmetics in the last decade (2012–2022). We found that ultrasound-assisted extraction, solid phase extraction, and microextraction coupled with chromatographic analysis are still the most widely used analytical technologies for hormones in cosmetics. Through the investigation of market status, the summary of sample pretreatment and detection technologies, as well as the discussion of their development trends in the future, our purpose is to provide a reference for the supervision of illegal hormone residues in cosmetics. Full article
(This article belongs to the Special Issue Development of Sample Preparation and Analytical Methods)
Show Figures

Figure 1

Figure 1
<p>Sample preparation and detection techniques for hormones in cosmetics are included in this review.</p>
Full article ">Figure 2
<p>(<b>a</b>) The unqualified cosmetic batches containing hormones and (<b>b</b>) their detection values in China in recent six years (2017–2022). (<b>c</b>). Hormone types, frequency, and (<b>d</b>) cosmetic types in the above unqualified cosmetic batches.</p>
Full article ">Figure 3
<p>(<b>a</b>) Scheme of sorption-based extraction technique for SPE. Reprinted with permission from Ref. [<a href="#B15-molecules-28-01980" class="html-bibr">15</a>] Copyright 2017 Journal of Separation Science. (<b>b</b>) Synthesis of plate@MWCNTs@MIPs and their application for SPE. Reprinted with permission from Ref. [<a href="#B52-molecules-28-01980" class="html-bibr">52</a>] Copyright 2018 Journal of Colloid and Interface Science. (<b>c</b>) Synthesis of magnetic MIPs and their application for MSPE. Reprinted with permission from Ref. [<a href="#B59-molecules-28-01980" class="html-bibr">59</a>] Copyright 2018 Journal of Separation Science.</p>
Full article ">Figure 4
<p>(<b>a</b>) Scheme of the MIL as an extraction solvent for DLLME. Reprinted with permission from Ref. [<a href="#B66-molecules-28-01980" class="html-bibr">66</a>] Copyright 2020 Talanta. (<b>b</b>) Scheme for the synthesis of ACB[6]@poly(BMA-EDMA) monolith for PMME. Reprinted with permission from Ref. [<a href="#B68-molecules-28-01980" class="html-bibr">68</a>] Copyright 2015 New Journal of Chemistry. (<b>c</b>) Scheme of the preparation of porous monolithic polymer extraction bars and the procedure of µ-SPE. Reprinted with permission from Ref. [<a href="#B69-molecules-28-01980" class="html-bibr">69</a>] Copyright 2020 Journal of Separation Science.</p>
Full article ">Figure 5
<p>(<b>a</b>) Scheme of the conventional immunoassay format approaches and the LFIA principle for on-site applications. Reprinted with permission from Ref. [<a href="#B25-molecules-28-01980" class="html-bibr">25</a>] Copyright 2021 Processes. (<b>b</b>) The application of a LFIA assay to rapidly test for dexamethasone in commercial facial masks. Reprinted with permission from Ref. [<a href="#B85-molecules-28-01980" class="html-bibr">85</a>] Copyright 2019 Analytical and Bioanalytical Chemistry. (<b>c</b>) The UCNPs-LFIA for triamcinolone acetonide detection. Reprinted with permission from Ref. [<a href="#B87-molecules-28-01980" class="html-bibr">87</a>] Copyright 2019 Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.</p>
Full article ">
15 pages, 2690 KiB  
Article
68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake
by Lei Wang, Ivica Jerolim Bratanovic, Zhengxing Zhang, Hsiou-Ting Kuo, Helen Merkens, Jutta Zeisler, Chengcheng Zhang, Ruiyan Tan, François Bénard and Kuo-Shyan Lin
Molecules 2023, 28(4), 1977; https://doi.org/10.3390/molecules28041977 - 20 Feb 2023
Cited by 5 | Viewed by 2364
Abstract
With overexpression in various cancers, the gastrin-releasing peptide receptor (GRPR) is a promising target for cancer imaging and therapy. However, the high pancreas uptake of reported GRPR-targeting radioligands limits their clinical application. Our goal was to develop 68Ga-labeled agonist tracers for detecting [...] Read more.
With overexpression in various cancers, the gastrin-releasing peptide receptor (GRPR) is a promising target for cancer imaging and therapy. However, the high pancreas uptake of reported GRPR-targeting radioligands limits their clinical application. Our goal was to develop 68Ga-labeled agonist tracers for detecting GRPR-expressing tumors with positron emission tomography (PET), and compare them with the clinically validated agonist PET tracer, [68Ga]Ga-AMBA. Ga-TacBOMB2, TacBOMB3, and TacBOMB4, derived from [Thz14]Bombesin(7–14), were confirmed to be GRPR agonists by a calcium mobilization study, and their binding affinities (Ki(GRPR)) were determined to be 7.62 ± 0.19, 6.02 ± 0.59, and 590 ± 36.5 nM, respectively, via in vitro competition binding assays. [68Ga]Ga-TacBOMB2, [68Ga]Ga-TacBOMB3, and [68Ga]Ga-AMBA clearly visualized PC-3 tumor xenografts in a PET imaging study. [68Ga]Ga-TacBOMB2 showed comparable tumor uptake but superior tumor-to-background contrast ratios when compared to [68Ga]Ga-AMBA. Moreover, [68Ga]Ga-TacBOMB2 and [68Ga]Ga-TacBOMB3 showed a much lower rate of uptake in the pancreas (1.30 ± 0.14 and 2.41 ± 0.72%ID/g, respectively) than [68Ga]Ga-AMBA (62.4 ± 4.26%ID/g). In conclusion, replacing Met14 in the GRPR-targeting sequence with Thz14 retains high GRPR-binding affinity and agonist properties. With good tumor uptake and tumor-to-background uptake ratios, [68Ga]Ga-TacBOMB2 is promising for detecting GRPR-expressing tumors. The much lower pancreas uptake of [68Ga]Ga-TacBOMB2 and [68Ga]Ga-TacBOMB3 suggests that [Thz14]Bombesin(7–14) is a promising targeting vector for the design of GRPR-targeting radiopharmaceuticals, especially for radioligand therapy application. Full article
(This article belongs to the Special Issue Design, Synthesis and Evaluation of Theranostic Radiopharmaceuticals)
Show Figures

Figure 1

Figure 1
<p>Chemical structures of (<b>A</b>) TacsBOMB2, TacsBOMB3, and TacsBOMB4; (<b>B</b>) TacsBOMB5; (<b>C</b>) TacBOMB2, TacBOMB3, and TacBOMB4; and (<b>D</b>) AMBA. The reduced peptide bond (inside the dashed brown circle) for the compounds in (<b>A</b>) is replaced with an amide bond (inside the dashed brown circle) for the compounds in (<b>C</b>).</p>
Full article ">Figure 2
<p>Intracellular calcium efflux in PC-3 cells induced by various tested ligands. Error bars indicate standard deviation.</p>
Full article ">Figure 3
<p>Displacement curves of [<sup>125</sup>I-Tyr<sup>4</sup>]Bombesin by Ga-TacBOMB2, Ga-TacBOMB3, Ga-TacBOMB4, and Ga-AMBA generated using GRPR-expressing PC-3 cells. Error bars indicate standard deviation.</p>
Full article ">Figure 4
<p>Representative PET images of [<sup>68</sup>Ga]Ga-TacBOMB2, [<sup>68</sup>Ga]Ga-TacBOMB3, and [<sup>68</sup>Ga]Ga-AMBA acquired at 1 h post-injection in mice bearing PC-3 tumor xenografts. t: tumor; k: kidney; p/i: pancreas/intestines; bl: urinary bladder.</p>
Full article ">Figure 5
<p>Uptake of [<sup>68</sup>Ga]Ga-TacBOMB2, [<sup>68</sup>Ga]Ga-TacBOMB3, and [<sup>68</sup>Ga]Ga-AMBA in PC-3 tumor xenografts and major organs/tissues of mice at 1 h post-injection. Error bars indicate standard deviation (<span class="html-italic">n</span> = 4).</p>
Full article ">Figure 6
<p>Comparison of tumor-to-organ contrast ratios of [<sup>68</sup>Ga]Ga-TacBOMB2 and [<sup>68</sup>Ga]Ga-AMBA obtained from PC-3 tumor-bearing mice at 1 h post-injection. Error bars indicate standard deviation (<span class="html-italic">n</span> = 4). * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 7
<p>Comparison of [<sup>68</sup>Ga]Ga-TacBOMB2 with/without co-injection of [D-Phe<sup>6</sup>,Leu-NHEt<sup>13</sup>,des-Met<sup>14</sup>]Bombesin(6–14) on the uptake in PC-3 tumor xenografts and major organs/tissues in mice at 1 h post-injection. Error bars indicate standard deviation (<span class="html-italic">n</span> = 4). * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">
12 pages, 5717 KiB  
Article
Lactose and Galactose Promote the Crystallization of Human Galectin-10
by Yu-Fan Fu, Si-Cong Jiang, Zhong-Wei Zhang, Xin-Yue Yang, Zi-Lin Li, Jing Hu and Shu Yuan
Molecules 2023, 28(4), 1979; https://doi.org/10.3390/molecules28041979 - 19 Feb 2023
Cited by 2 | Viewed by 2680
Abstract
Galectin-10 (Gal-10) forms Charcot–Leyden crystals (CLCs), which play a key role in the symptoms of asthma and allergies and some other diseases. Gal-10 has a carbohydrate-binding site; however, neither the Gal-10 dimer nor the CLCs can bind sugars. To investigate the monomer–dimer equilibrium [...] Read more.
Galectin-10 (Gal-10) forms Charcot–Leyden crystals (CLCs), which play a key role in the symptoms of asthma and allergies and some other diseases. Gal-10 has a carbohydrate-binding site; however, neither the Gal-10 dimer nor the CLCs can bind sugars. To investigate the monomer–dimer equilibrium of Gal-10, high-performance size-exclusion chromatography (SEC) was employed to separate serial dilutions of Gal-10 with and without carbohydrates. We found that both the dimerization and crystallization of Gal-10 were promoted by lactose/galactose binding. A peak position shift for the monomer was observed after treatment with either lactose or galactose, implying that the polarity of the monomer was reduced by lactose/galactose binding. Further experiments indicated that alkaline conditions of pH 8.8 mimicked the lactose/galactose-binding environment, and the time interval between monomers and dimers in the chromatogram decreased from 0.8 min to 0.4 min. Subsequently, the electrostatic potential of the Gal-10 monomers was computed. After lactose/galactose binding, the top side of the monomer shifted from negatively charged to electrically neutral, allowing it to interact with the carbohydrate-binding site of the opposing subunit during dimerization. Since lactose/galactose promotes the crystallization of Gal-10, our findings implied that dairy-free diets (free of lactose/galactose) might be beneficial to patients with CLC-related diseases. Full article
(This article belongs to the Special Issue Recent Opinion on Protein-Carbohydrate Interactions)
Show Figures

Figure 1

Figure 1
<p>Concentration-dependent and time-dependent dimer formation of Gal-10 and the effects of carbohydrate binding. (<b>A</b>–<b>C</b>) Concentration-dependent dimerization of Gal-10. The protein was diluted to 100 μM, 10 μM, and 1 μM and incubated for 2 h. (<b>D</b>) Time-dependent dimer formation of Gal-10. The protein was diluted to 10 μM and incubated for 0 h, 2 h, 12 h, and 24 h. (<b>E</b>) Effects of sugars on Gal-10 monomer–dimer equilibrium. Gal-10 was diluted to 10 μM and incubated with 1 mM lactose, galactose, sucrose, or glucose for 2 h. The samples were analyzed by SEC HPLC using PBS–azide buffer (pH 7.4).</p>
Full article ">Figure 2
<p>Effect of pH on Gal-10 monomer–dimer equilibrium. The protein was diluted to 10 μM in PBS–azide buffer at pH 8.8 (<b>A</b>), 7.4 (<b>B</b>), and 6.0 (<b>C</b>) with or without 1 mM lactose and incubated for 24 h. The samples were analyzed by SEC HPLC using PBS–azide buffer at pH 8.8 (<b>A</b>), 7.4 (<b>B</b>), and 6.0 (<b>C</b>). Quantitative data of Gal-10 monomers and dimers are shown on the left side of each panel. Bars represent the standard deviations of three independent replicates.</p>
Full article ">Figure 3
<p>Effects of sugars on Gal-10 crystallization. Gal-10 was diluted to 10 μM in PBS–azide buffer with 0.01% Coomassie brilliant blue R-250 and incubated with or without 1 mM lactose, galactose, sucrose, or glucose for 24 h. The crystals were observed under a light microscope. Bar = 50 μM.</p>
Full article ">Figure 4
<p>Effects of pH on Gal-10 crystallization. Gal-10 was diluted to 10 µM in PBS–azide buffer at pH 8.8, 7.4, and 6.0, with 0.01% Coomassie brilliant blue R-250 and incubated with or without 1 mM lactose for 24 h. The crystals were observed under a light microscope. Bar = 50 μM.</p>
Full article ">Figure 5
<p>Shift in electrostatic potential may affect Gal-10 dimerization and crystallization. Given that Trp72, His53, and Asn65 bind with lactose (marked with green), the molecular surface and the electrostatic potential were re-computed by replacing Trp72, His53, and Asn65 with Ala to simulate the conditions of carbohydrate binding. Glu33 (marked with pale lavender) from one Gal-10 monomer subunit interacted with the carbohydrate-binding site of the opposing subunit when dimerizing. Then, lactose was expelled from the Gal-10 monomer after dimerization. The red-to-blue color gradient on the molecular surface indicates the electrostatic potential (red: −1.8; blue: 1.8).</p>
Full article ">
13 pages, 5549 KiB  
Article
Reversible Luminescent Switching Induced by Heat/Water Treatment in a Zero-Dimensional Hybrid Antimony(Ⅲ) Chloride
by Ying-Chen Peng, Hao-Wei Lin, Sheng-Hua Zhou, Jian-Ce Jin, Ting-Hui Zhuang, Abdusalam Ablez, Ze-Ping Wang, Ke-Zhao Du and Xiao-Ying Huang
Molecules 2023, 28(4), 1978; https://doi.org/10.3390/molecules28041978 - 19 Feb 2023
Cited by 10 | Viewed by 2768
Abstract
Recently zero-dimensional (0-D) inorganic–organic metal halides (IOMHs) have become a promising class of optoelectronic materials. Herein, we report a new photoluminescent (PL) 0-D antimony(III)-based IOMH single crystal, namely [H2BPZ][SbCl5]·H2O (BPZ = benzylpiperazine). Photophysical characterizations indicate that [H [...] Read more.
Recently zero-dimensional (0-D) inorganic–organic metal halides (IOMHs) have become a promising class of optoelectronic materials. Herein, we report a new photoluminescent (PL) 0-D antimony(III)-based IOMH single crystal, namely [H2BPZ][SbCl5]·H2O (BPZ = benzylpiperazine). Photophysical characterizations indicate that [H2BPZ][SbCl5]·H2O exhibits singlet/triplet dual-band emission. Density functional theory (DFT) calculations suggest that [H2BPZ][SbCl5]·H2O has the large energy difference between singlet and triplet states, which might induce the dual emission in this compound. Temperature-dependent PL spectra analyses suggest the soft lattice and strong electron–phonon coupling in this compound. Thermogravimetric analysis shows that the water molecules in the lattice of the title crystal could be removed by thermal treatment, giving rise to a dehydrated phase of [H2BPZ][SbCl5]. Interestingly, such structural transformation is accompanied by a reversible PL emission transition between red light (630 nm, dehydrated phase) and yellow light (595 nm, water-containing phase). When being exposed to an environment with 77% relative humidity, the emission color of the dehydrated phase was able to change from red to yellow within 20 s, and the red emission could be restored after reheating. The red to yellow emission switching could be achieved in acetone with water concentration as low as 0.2 vol%. The reversible PL transition phenomenon makes [H2BPZ][SbCl5]·H2O a potential material for luminescent water-sensing. Full article
Show Figures

Figure 1

Figure 1
<p>Structural diagrams for the title crystal [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O. A [H<sub>2</sub>BPZ]<sup>2+</sup> cation (<b>a</b>) and a [SbCl<sub>5</sub>]<sup>2−</sup> anion (<b>b</b>) in [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O. (<b>c</b>) Unit-cell-packing diagram viewed down the <span class="html-italic">a</span>-axis. (<b>d</b>) A supramolecular layer in [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O viewed along the <span class="html-italic">b</span>-axis in which lattice water molecules are located; water molecules are in CPK mode; hydrogen bonds with water molecules are not shown for clarity. (<b>e</b>) Topological net of <span class="html-italic">pcu</span> type for anions arrangement in [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O where the lattice water molecules are shown.</p>
Full article ">Figure 2
<p>Steady-state and time-resolved PL spectra of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O at RT. (<b>a</b>) The steady-state PLE spectra of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O, measured with emission wavelengths at 450 and 595 nm, respectively. (<b>b</b>) The steady-state PL spectra of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O with excitation wavelengths at 290 and 320 nm, respectively. (<b>c</b>) Time-resolved PL spectrum of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O at 595 nm emission. The PL lifetime is fitted, calculated, and labelled. (<b>d</b>) The proposed PL mechanism in the configuration coordinate diagram.</p>
Full article ">Figure 3
<p>Temperature-dependent PL spectra and fitted physical parameters. Temperature-dependent PL spectra (<b>a</b>) and contour map (<b>b</b>) of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O under the excitation of 320 nm. (<b>c</b>) Full width at half maximum (FWHM) vs. temperature (<span class="html-italic">T</span>) fitted by Equation (3). (<b>d</b>) FWHM vs. 1/<span class="html-italic">T</span> fitted by Equation (4).</p>
Full article ">Figure 4
<p>(<b>a</b>) The calculated orbital-resolved DOSs of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O. The highest occupied molecular orbital (HOMO; (<b>b</b>)) and lowest occupied molecular orbital (LUMO; (<b>c</b>)) along the <span class="html-italic">ac</span> plane of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O.</p>
Full article ">Figure 5
<p>(<b>a</b>) The experimental PXRD patterns for as-made [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O and that storing at ambient conditions for one month compared with the one simulated from SCXRD data. (<b>b</b>) The TG curve for [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O; the theoretical and experimental weight losses of water molecules in the crystal lattice were calculated and labelled.</p>
Full article ">Figure 6
<p>(<b>a</b>) The in situ PL spectra for humidity-sensing application; the red-emissive [H<sub>2</sub>BPZ][SbCl<sub>5</sub>] can be transformed to yellow-emissive [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O within 20 s under the ambient condition. Inset: the photographs of [H<sub>2</sub>BPZ][SbCl<sub>5</sub>]·H<sub>2</sub>O power under ambient light (top) and UV light (bottom); from left to right: freshly prepared crystals, samples after heating at 100 °C for 30 min, dehydrated samples placed in ambient condition. (<b>b</b>) Dehydrated [H<sub>2</sub>BPZ][SbCl<sub>5</sub>] in acetone solvent containing different amounts of water (0–0.4% <span class="html-italic">v</span>/<span class="html-italic">v</span>).</p>
Full article ">
17 pages, 3426 KiB  
Article
Influence of Mutations of Conserved Arginines on Neuropeptide Binding in the DPP III Active Site
by Antonija Tomić, Zrinka Karačić and Sanja Tomić
Molecules 2023, 28(4), 1976; https://doi.org/10.3390/molecules28041976 - 19 Feb 2023
Cited by 1 | Viewed by 1960
Abstract
Dipeptidyl peptidase III (DPP III), a zinc exopeptidase, is involved in the final steps of intercellular protein degradation and has a marked affinity for opioid peptides such as enkephalins and endomorphins. Recently, we characterized a number of neuropeptides as potential substrates and inhibitors [...] Read more.
Dipeptidyl peptidase III (DPP III), a zinc exopeptidase, is involved in the final steps of intercellular protein degradation and has a marked affinity for opioid peptides such as enkephalins and endomorphins. Recently, we characterized a number of neuropeptides as potential substrates and inhibitors of human DPP III and provided an explanation for their differential behavior. These studies prompted us to investigate the influence of the conserved R399 and R669 on neuropeptides binding to DPP III. Measuring kinetic parameters in inhibitory assays, we found that mutation of R669 to Ala or Met significantly reduced the inhibitory properties of the slow substrates tynorphin and valorphin, whereas the effects on binding of the good substrates Arg2-2NA and Leu-enkephalin were small. Molecular dynamics simulations of wild-type (WT) and mutant DPP III complexes with Leu-enkephalin, tynorphin, valorphin, and Arg2-2NA in conjunction with calculations of binding free energies revealed that the lower inhibitory potency of slow substrates in the R669A mutant can be explained by the lower binding affinity of tynorphin and the higher propensity of valorphin to hydrolyze in the mutant than in WT. The R399A mutation was shown to affect the binding and/or hydrolysis of both good and slow substrates, with the effects on Leu-enkephalin being the most pronounced. Full article
Show Figures

Figure 1

Figure 1
<p>Location of the mutated arginine residues in the unbound enzyme structure from the PDB with code 5EGY. The lower protein domain residues (1–336, 375–420, and 669–726) are colored light pink, and the upper domain residues (337–374 and 421–668) are in gray. The flexible loop (residues 463–489) is colored black. The hinge (residues 409–420) involved in the conformational change of the protein is cyan, and the β-strand to which the ligand binds is colored blue. The zinc ion is colored magenta. Arginines 669 and 399 are in orange and green, with N and O atoms in red and blue.</p>
Full article ">Figure 2
<p>The MM/GBSA per-residue binding-free energies indicate how much each ligand residue contributes to the binding-free energy. Calculations were performed using the set of conformers sampled during the last 800 ns of the MD simulations of the complexes. The amino acid residues of the peptide ligand are denoted as P1 to Pn and P1’ to Pn’, counting from the scissile peptide bond to the N- and C-termini of the peptides, respectively.</p>
Full article ">Figure 3
<p>Hydrogen bond occupancy (shown only when occupancy &gt; 20% in at least one complex) calculated by using the Hbonds plugin (VMD) between the ligand and the rest of the protein. Angle and distance cut-offs were 45° and 3 Å, respectively. Indicated amino acids participated as hydrogen bond donor and/or acceptors (for more details see <a href="#app1-molecules-28-01976" class="html-app">Figure S3</a>). When applicable, it is also indicated whether only the atoms of the side chain (s) or of the main chain (m) were involved in hydrogen bonding.</p>
Full article ">Figure 3 Cont.
<p>Hydrogen bond occupancy (shown only when occupancy &gt; 20% in at least one complex) calculated by using the Hbonds plugin (VMD) between the ligand and the rest of the protein. Angle and distance cut-offs were 45° and 3 Å, respectively. Indicated amino acids participated as hydrogen bond donor and/or acceptors (for more details see <a href="#app1-molecules-28-01976" class="html-app">Figure S3</a>). When applicable, it is also indicated whether only the atoms of the side chain (s) or of the main chain (m) were involved in hydrogen bonding.</p>
Full article ">Figure 4
<p>Binding of valorphin (<b>a</b>) and tynorphin (<b>b</b>) with the wild-type (cyan) and the R669A mutated (magenta) DPP III enzymes. Shown are optimized structures obtained after 1 µs of MD simulations. The amino acid residues that formed hydrogen bonds (indicated by dashed lines) with the ligand are shown as thin sticks, as are the amino acid residues that formed polar interactions with the ligand. Mutated residues are also shown as thin sticks. The β-sheet (residues A388-N391) from the lower protein domain involved in antiparallel binding of the ligand is shown as an opaque cartoon. The zinc ion is shown as a sphere. The hydrogen atoms are not shown, nor are the main chain atoms, except at A699.</p>
Full article ">Figure 5
<p>Binding of Arg<sub>2</sub>-2NA in the binding site of the wild-type (cyan) and the mutated (R399A in yellow and R669A in magenta) DPP III enzymes. Shown are optimized structures obtained after 1 µs of MD simulations. The mutated amino acids and the amino acid residues that form polar interactions/hydrogen bonds with the ligand are shown as thin sticks. The β-sheet (residues A388-N391) from the lower protein domain involved in antiparallel binding of the ligand is shown as an opaque cartoon. The zinc ion is shown as a sphere.</p>
Full article ">Figure 6
<p>Box plots of (<b>a</b>) the distance between the zinc ion and the peptide carbonyl oxygen atom (O) at the P1 position and (<b>b</b>) the angle defining the direction of OH<sup>−</sup> attack calculated between the carbonyl oxygen (O) and carbon (C) of the residue in position P1 and the oxygen atom of the activated water molecule (Ow). The activated water molecule simultaneously coordinated Zn and was hydrogen bonded to E451. The whiskers depict one standard deviation.</p>
Full article ">Figure 7
<p>Binding of Leu-enkephalin with the wild-type (<b>a</b>) and the R399A mutant (<b>b</b>) DPP III - structures obtained after 1 µs of MD simulations. The Leu-enkephalin structures sampled every 100 ns (starting from 200th ns) are shown as sticks and colored according to their position in the trajectory (in light red at the 200th ns, in white in the middle of the trajectory, and in blue at the end). The β-sheet (residues A388-N391) from the lower protein domain involved in antiparallel binding of the ligand is shown as an opaque cartoon and is colored green. The zinc ion is shown as a yellow sphere. The hydrogen atoms are not shown.</p>
Full article ">
15 pages, 1598 KiB  
Article
Variation of Aroma Components of Pasteurized Yogurt with Different Process Combination before and after Aging by DHS/GC-O-MS
by Mu Zhao, Hongliang Li, Dongjie Zhang, Jie Li, Rong Wen, Hairan Ma, Tingting Zou, Yaqiong Hou and Huanlu Song
Molecules 2023, 28(4), 1975; https://doi.org/10.3390/molecules28041975 - 19 Feb 2023
Cited by 7 | Viewed by 2844
Abstract
Pasteurized yogurt is a healthy yogurt that can be stored in ambient temperature conditions. Dynamic headspace sampling (DHS) combined with gas chromatography-olfactory mass spectrometry (GC-O-MS), sensory evaluation, electronic nose (E-nose), and partial least squares discriminant analysis (PLS-DA) were used to analyze the flavor [...] Read more.
Pasteurized yogurt is a healthy yogurt that can be stored in ambient temperature conditions. Dynamic headspace sampling (DHS) combined with gas chromatography-olfactory mass spectrometry (GC-O-MS), sensory evaluation, electronic nose (E-nose), and partial least squares discriminant analysis (PLS-DA) were used to analyze the flavor changes of pasteurized yogurt with different process combinations before and after aging. The results of odor profiles showed that the sensory descriptors of fermented, sweet, and sour were greatly affected by different process combinations. The results of odor-active compounds and relative odor activity value (r-OAV) showed that the combination of the production process affected the overall odor profile of pasteurized yogurt, which was consistent with the sensory evaluation results. A total of 15 odor-active compounds of 38 volatile compounds were detected in pasteurized yogurt samples. r-OAV results revealed that hexanal, (E)-2-octenal, 2-heptanone, and butanoic acid may be important odor-active compounds responsible for off-odor in aged, pasteurized yogurt samples. PLS-DA and variable importance of projection (VIP) results showed that butanoic acid, hexanal, acetoin, decanoic acid, 1-pentanol, 1-nonanal, and hexanoic acid were differential compounds that distinguish pasteurized yogurt before and after aging. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Odor profile evaluation of the six samples.</p>
Full article ">Figure 2
<p>Radar chart and PCA analysis by E-nose. (<b>A</b>) Radar chart of the E-nose response of different types of volatiles for different pasteurized yogurt samples, (<b>B</b>) PCA plot of the E-nose for different pasteurized yogurt samples.</p>
Full article ">Figure 3
<p>The heat map analysis of the six samples. Every square represents a volatile compound. If a compound had a lower concentration, the color of the square is close to blue, otherwise, the color is close to red.</p>
Full article ">Figure 4
<p>2D (<b>A</b>) and 3D (<b>B</b>) score charts of PLS-DA and VIP diagram (<b>C</b>; red means VIP &gt; 1, green means VIP &lt; 1) of the six samples (R<sup>2</sup>X = 0.919, R<sup>2</sup>Y = 0.98, and Q<sup>2</sup> = 0.88).</p>
Full article ">
13 pages, 3314 KiB  
Article
Cinnamomum japonicum Siebold Branch Extracts Attenuate NO and ROS Production via the Inhibition of p38 and JNK Phosphorylation
by Jae Min Kim, Moon-Hee Choi and Ji Hye Yang
Molecules 2023, 28(4), 1974; https://doi.org/10.3390/molecules28041974 - 19 Feb 2023
Cited by 1 | Viewed by 1914
Abstract
Cinnamomum japonicum (CJ) is widely distributed in Asian countries like Korea, China, and Japan. Modern pharmacological studies have demonstrated that it exhibits various biological activities, including antioxidant and anti-inflammatory effects. However, most studies have confirmed the efficacy of its water extract but not [...] Read more.
Cinnamomum japonicum (CJ) is widely distributed in Asian countries like Korea, China, and Japan. Modern pharmacological studies have demonstrated that it exhibits various biological activities, including antioxidant and anti-inflammatory effects. However, most studies have confirmed the efficacy of its water extract but not that of its other extracts. Therefore, in this study, Cinnamomum japonicum Siebold branches (CJB: 70% EtOH extract) were separated using hexane, chloroform, ethyl acetate (CJB3), butanol, and water. Then, their antioxidative activities and phenolic contents were measured. Results revealed that the antioxidant activities and phenolic contents of CJB3 were higher than those of the other extracts. Further, the inhibitory and anti-inflammatory effect of CJB3 on lipopolysaccharide (LPS)-induced reactive oxygen species (ROS) production and LPS-activated macrophages, respectively, was determined. CJB3 suppressed oxidative stress in LPS-activated cells and dose-dependently decreased LPS-stimulated ROS production. CJB3 reduced oxidative stress and reversed the glutathione decrease in LPS-activated RAW264.7 cells. The inhibitory and reducing effect of CJB3 on LPS-induced nitric oxide (NO) production and inducible NO synthase protein and messenger RNA levels, respectively, was investigated. CJB3 inhibited LPS-induced cytokine production and p38 and c-Jun N-terminal kinase (JNK) phosphorylation but not extracellular signal-regulated kinase phosphorylation. Overall, the study results suggest that CJB3 may exert its anti-inflammatory effects via the suppression of p38, JNK, and c-Jun activation. Full article
Show Figures

Figure 1

Figure 1
<p>Isolation and fractionation diagram of <span class="html-italic">Cinnamomum japonicum</span> Sieb. Branch.</p>
Full article ">Figure 2
<p>Antioxidant effect of <span class="html-italic">Cinnamomum japonicum</span> Sieb. Branch. Antioxidant activity results: 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS).</p>
Full article ">Figure 3
<p>HPLC profile of the CJB3 and standard mixtures using diode array detection at 280 nm. (<b>A</b>) Standards and (<b>B</b>) CJB3; the numbers indicate the following: (1) Epigallocatechin gallate (2) Epicatechin (3) <span class="html-italic">p</span>-Coumaric acid (4) Coumarin (5) Cinnamylacetate (6) Cinnamylalcohol (7) Trans-Cinnamic acid (8) Cinnamylaldehyde (9) Eugenol (10) Quercetin.</p>
Full article ">Figure 4
<p>The inhibitory effect of CJB3 on LPS-induced oxidative stress in RAW264.7 cells. (<b>A</b>) The cytotoxicity of CJB3 in Raw 264.7 cells: cells were treated with CJB3 (10–100 μg/mL) for 24 h, and cytotoxicity was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays. The effect of CJB3 on lipopolysaccharide (LPS)-induced reactive oxygen species (ROS) production: cells were treated with CJB3 (30 or 100 μg/mL) for 1 h and incubated with LPS for 3 h. (<b>B</b>) Cells were stained with 10 μM 2′-7′-dichlorofluorescin diacetate (DCFH-DA) for 30 min at 37 °C. Intracellular fluorescence intensities were measured using a fluorescence microplate reader. (<b>C</b>) The glutathione (GSH) concentrations were measured in the cell lysates treated with LPS and/or 10–30 μg/mL CJB3 for 12 h. Data are expressed as the mean ± standard error of the mean (SE) of three replicates; ** <span class="html-italic">p</span> &lt; 0.01, * <span class="html-italic">p</span> &lt; 0.05, significant vs. vehicle-treated control; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, significant vs. LPS alone.</p>
Full article ">Figure 5
<p>CJB3-mediated inhibition of LPS-induced NO production and iNOS expression. (<b>A</b>) Nitric oxide (NO) production: cells were treated with CJB3 (10–100 μg/mL) and/or LPS for 15 h, and NO production was measured using a Griess reagent. (<b>B</b>) CJB3-mediated inhibition of inducible NO synthase (iNOS) expression in LPS-activated RAW264.7 cells: cells were pretreated with varying concentrations of CJB3 (10–100 μg/mL) for 1 h and incubated with LPS (100 ng/mL) for 12 h. iNOS protein levels in the cell lysates were measured using western blot. (<b>C</b>) The iNOS transcripts were analyzed using RT-PCR assays: cells were pretreated with 30–100 μg/mL CJB3 for 1 h and incubated with 100 ng/mL LPS for 6 h. Data are expressed as the mean ± SE of three replicates; ** <span class="html-italic">p</span> &lt; 0.01., significant vs. vehicle-treated control; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, significant vs. LPS alone.</p>
Full article ">Figure 6
<p>CJB3-mediated inhibition of LPS-induced proinflammatory cytokine expression. (<b>A</b>,<b>B</b>) Measurement of the inhibitory effect of CJB3 on proinflammatory cytokine expression: cells were treated with 30 or 100 μg/mL CJB3 for 1 h and incubated with LPS for 6 h. (<b>A</b>) Tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) transcripts were monitored using RT-PCR assays. (<b>B</b>) Enzyme-linked immunosorbent assay (ELISA): TNF-α and IL-6 release into the culture supernatant was determined using ELISA. Data are expressed as the mean ± SE of three replicates; ** <span class="html-italic">p</span> &lt; 0.01, significant vs. vehicle-treated control; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, significant vs. LPS alone.</p>
Full article ">Figure 7
<p>CJB3-induced specific inhibition of c-Jun, p38 and JNK phosphorylation in LPS-activated RAW264.7 cells. (<b>A</b>) Immunoblotting for total IκBα: cells were pretreated with CJB3 for 1 h before LPS stimulation for 15 min. Total IκBα in the cell lysate was immunoblotted. (<b>B</b>) The expression level of p65 protein in cells with nuclear fraction. Using Lamin as control for nuclear fraction. RAW264.7 cells were pretreated CJB3 for 1 h and then incubated with LPS for 3 h. (<b>C</b>) Immunoblotting for c-Jun and c-Fos phosphorylation: cells were pretreated with CJB3 for 1 h before LPS stimulation for 2 h, and cell lysates were immunoblotted to examine c-Jun and c-Fos phosphorylation. (<b>D</b>) Effect of CJB3 on LPS-induced phosphorylations of MAPKs: cells were treated with CJB3 for 1 h before LPS stimulation for 30 min. Data are expressed as the mean ± SE of three replicates; ** <span class="html-italic">p</span> &lt; 0.01, significant vs. vehicle-treated control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, significant vs. LPS alone.</p>
Full article ">
35 pages, 5802 KiB  
Review
The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by Duong Tien Anh, Nguyen Hai Nam, Brigitte Kircher and Daniel Baecker
Molecules 2023, 28(4), 1973; https://doi.org/10.3390/molecules28041973 - 19 Feb 2023
Cited by 6 | Viewed by 3530
Abstract
In recent years, histone deacetylases (HDACs) have emerged as promising targets in the treatment of cancer. The approach is to inhibit HDACs with drugs known as HDAC inhibitors (HDACis). Such HDACis are broadly classified according to their chemical structure, e.g., hydroxamic acids, benzamides, [...] Read more.
In recent years, histone deacetylases (HDACs) have emerged as promising targets in the treatment of cancer. The approach is to inhibit HDACs with drugs known as HDAC inhibitors (HDACis). Such HDACis are broadly classified according to their chemical structure, e.g., hydroxamic acids, benzamides, thiols, short-chain fatty acids, and cyclic peptides. Fluorination plays an important role in the medicinal–chemical design of new active representatives. As a result of the introduction of fluorine into the chemical structure, parameters such as potency or selectivity towards isoforms of HDACs can be increased. However, the impact of fluorination cannot always be clearly deduced. Nevertheless, a change in lipophilicity and, hence, solubility, as well as permeability, can influence the potency. The selectivity towards certain HDACs isoforms can be explained by special interactions of fluorinated compounds with the structure of the slightly different enzymes. Another aspect is that for a more detailed investigation of newly synthesized fluorine-containing active compounds, fluorination is often used for the purpose of labeling. Aside from the isotope 19F, which can be detected by nuclear magnetic resonance spectroscopy, the positron emission tomography of 18F plays a major role. However, to our best knowledge, a survey of the general effects of fluorination on HDACis development is lacking in the literature to date. Therefore, the aim of this review is to highlight the introduction of fluorine in the course of chemical synthesis and the impact on biological activity, using selected examples of recently developed fluorinated HDACis. Full article
(This article belongs to the Special Issue Bioorganic Chemistry: Current and Future Perspectives)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structures of some HDACis considering the pharmacophore consisting of cap, linker, and zinc-binding group (ZBG).</p>
Full article ">Figure 2
<p>Chemical structure of largazole.</p>
Full article ">Figure 3
<p>Chemical structures of fluorinated hydroxamic acids by Salmi-Smail et al. [<a href="#B68-molecules-28-01973" class="html-bibr">68</a>].</p>
Full article ">Figure 4
<p>Chemical structures of fluorinated hydroxamic acids by Luckhurst [<a href="#B69-molecules-28-01973" class="html-bibr">69</a>].</p>
Full article ">Figure 5
<p>Chemical structure of fluorinated hydroxamic acid by Yao, Li et al. [<a href="#B70-molecules-28-01973" class="html-bibr">70</a>].</p>
Full article ">Figure 6
<p>Chemical structure of fluorinated hydroxamic acid (PTG-0861) by Gawel, Shouksmith, Raouf, Nawar et al. [<a href="#B71-molecules-28-01973" class="html-bibr">71</a>].</p>
Full article ">Figure 7
<p>Chemical structure of fluorinated benzamide (CBUD-1001) by Kim, La et al. [<a href="#B72-molecules-28-01973" class="html-bibr">72</a>].</p>
Full article ">Figure 8
<p>Chemical structure of Merck60.</p>
Full article ">Figure 9
<p>Chemical structures of fluorinated hydroxamic acids by Chen et al. [<a href="#B80-molecules-28-01973" class="html-bibr">80</a>,<a href="#B81-molecules-28-01973" class="html-bibr">81</a>].</p>
Full article ">Figure 10
<p>Chemical structure of fluorinated hydroxamic acids by Sandrone et al. [<a href="#B83-molecules-28-01973" class="html-bibr">83</a>].</p>
Full article ">Figure 11
<p>Chemical structures of fluorinated HDAC6-addressing PROTACs by Keuler, König, Bückreiß et al. [<a href="#B85-molecules-28-01973" class="html-bibr">85</a>].</p>
Full article ">Figure 12
<p>Chemical structure of fluorinated BLT by Sankaranarayanapillai et al. [<a href="#B86-molecules-28-01973" class="html-bibr">86</a>,<a href="#B87-molecules-28-01973" class="html-bibr">87</a>].</p>
Full article ">Figure 13
<p>Chemical structures of four INER-1577 derivatives by Chen et al. [<a href="#B92-molecules-28-01973" class="html-bibr">92</a>].</p>
Full article ">Scheme 1
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids via reductive amination by Aboukhatwa et al. [<a href="#B33-molecules-28-01973" class="html-bibr">33</a>].</p>
Full article ">Scheme 2
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids via alkylation by Aboukhatwa et al. [<a href="#B33-molecules-28-01973" class="html-bibr">33</a>].</p>
Full article ">Scheme 3
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Wang et al. [<a href="#B34-molecules-28-01973" class="html-bibr">34</a>].</p>
Full article ">Scheme 4
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Goehringer, Peng, et al. [<a href="#B35-molecules-28-01973" class="html-bibr">35</a>].</p>
Full article ">Scheme 5
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Meyners et al. [<a href="#B36-molecules-28-01973" class="html-bibr">36</a>].</p>
Full article ">Scheme 6
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Toutah et al. [<a href="#B37-molecules-28-01973" class="html-bibr">37</a>].</p>
Full article ">Scheme 7
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Walton et al. [<a href="#B38-molecules-28-01973" class="html-bibr">38</a>].</p>
Full article ">Scheme 8
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Vu et al. [<a href="#B39-molecules-28-01973" class="html-bibr">39</a>].</p>
Full article ">Scheme 9
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Liu et al. [<a href="#B40-molecules-28-01973" class="html-bibr">40</a>].</p>
Full article ">Scheme 10
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Erdeljac et al. [<a href="#B41-molecules-28-01973" class="html-bibr">41</a>].</p>
Full article ">Scheme 11
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Ariawan et al. [<a href="#B42-molecules-28-01973" class="html-bibr">42</a>].</p>
Full article ">Scheme 12
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Strebl et al. [<a href="#B43-molecules-28-01973" class="html-bibr">43</a>].</p>
Full article ">Scheme 13
<p>Fluorination in the synthetic pathway of fluorinated hydroxamic acids by Hendricks, Keliher, et al. [<a href="#B44-molecules-28-01973" class="html-bibr">44</a>].</p>
Full article ">Scheme 14
<p>Fluorination in the two synthetic pathways (<b>A</b>,<b>B</b>) of fluorinated hydroxamic acids by Strebl et al. [<a href="#B45-molecules-28-01973" class="html-bibr">45</a>]. Radiochemical procedures for MGS1–2 (<b>A</b>) and MGS3 (<b>B</b>).</p>
Full article ">Scheme 15
<p>Fluorination in the synthetic pathway of fluorinated benzamides by Jayathilaka et al. [<a href="#B47-molecules-28-01973" class="html-bibr">47</a>].</p>
Full article ">Scheme 16
<p>Fluorination in the synthetic pathway of fluorinated benzamides by Bonomi et al. [<a href="#B48-molecules-28-01973" class="html-bibr">48</a>].</p>
Full article ">Scheme 17
<p>Fluorination in the synthetic pathway of fluorinated benzamides by La et al. [<a href="#B49-molecules-28-01973" class="html-bibr">49</a>].</p>
Full article ">Scheme 18
<p>Fluorination in the synthetic pathway of fluorinated benzamides via Suzuki reaction by Ibrahim et al. [<a href="#B50-molecules-28-01973" class="html-bibr">50</a>].</p>
Full article ">Scheme 19
<p>Fluorination in the synthetic pathway of fluorinated benzamides via amide-coupling reactions by Ibrahim et al. [<a href="#B50-molecules-28-01973" class="html-bibr">50</a>].</p>
Full article ">Scheme 20
<p>Fluorination in the synthetic pathway of fluorinated benzamides by Schäker-Hübner et al. [<a href="#B51-molecules-28-01973" class="html-bibr">51</a>].</p>
Full article ">Scheme 21
<p>Fluorination in the synthetic pathway of fluorinated benzamides by Liu et al. [<a href="#B40-molecules-28-01973" class="html-bibr">40</a>].</p>
Full article ">Scheme 22
<p>Fluorination in the radiosynthetic pathway of fluorinated benzamides by Bonomi et al. [<a href="#B48-molecules-28-01973" class="html-bibr">48</a>].</p>
Full article ">Scheme 23
<p>Fluorination in the radiosynthetic pathway of [<sup>18</sup>F] Fluoroethyl-INER1577 by Li et al. [<a href="#B52-molecules-28-01973" class="html-bibr">52</a>].</p>
Full article ">Scheme 24
<p>Fluorination in the radiosynthetic pathway of [<sup>18</sup>F] Fluoroethyl-INER1577 by Li et al. [<a href="#B53-molecules-28-01973" class="html-bibr">53</a>].</p>
Full article ">Scheme 25
<p>Fluorination in the synthetic pathway of fluorinated thiols by Chuman et al. [<a href="#B55-molecules-28-01973" class="html-bibr">55</a>].</p>
Full article ">Scheme 26
<p>Fluorination in the synthetic pathway of fluorinated thiols by Wen et al. [<a href="#B56-molecules-28-01973" class="html-bibr">56</a>].</p>
Full article ">Scheme 27
<p>Fluorination in the synthetic pathway of fluorinated short-chain fatty acids via alkylation by Lübke et al. [<a href="#B59-molecules-28-01973" class="html-bibr">59</a>].</p>
Full article ">Scheme 28
<p>Fluorination in the synthetic pathway of fluorinated short-chain fatty acids via bromofluorination by Lübke et al. [<a href="#B59-molecules-28-01973" class="html-bibr">59</a>].</p>
Full article ">Scheme 29
<p>Fluorination in the synthetic pathway of fluorinated cyclic peptides by Zhang, Liu, Gao, et al. [<a href="#B60-molecules-28-01973" class="html-bibr">60</a>,<a href="#B61-molecules-28-01973" class="html-bibr">61</a>].</p>
Full article ">
10 pages, 1830 KiB  
Article
Anti-Cancer Effects of Queen Bee Acid (10-Hydroxy-2-Decenoic Acid) and Its Cellular Mechanisms against Human Hepatoma Cells
by Zafer Saad Al Shehri, Abdullah D. Alanazi and Sultan F. Alnomasy
Molecules 2023, 28(4), 1972; https://doi.org/10.3390/molecules28041972 - 19 Feb 2023
Cited by 7 | Viewed by 3675
Abstract
Background: Hepatocellular carcinoma (HCC) is the most common form of liver cancer that occurs in hepatocytes. Although many chemical drugs, e.g., cisplatin, methotrexate, taxis, and doxorubicin are used to treat HCC, there have been numerous reports related to the side effects of these [...] Read more.
Background: Hepatocellular carcinoma (HCC) is the most common form of liver cancer that occurs in hepatocytes. Although many chemical drugs, e.g., cisplatin, methotrexate, taxis, and doxorubicin are used to treat HCC, there have been numerous reports related to the side effects of these drugs (e.g., emerging drug resistance, bone marrow failure, and gastrointestinal disorders). These issues led scientists to search for the novel anti-cancer drugs, mainly in natural products with greater efficiency and less toxicity. The current survey was intended to assess the anti-cancer effects of queen bee acid (10-Hydroxy-2-Decenoic Acid, 10-HDA) and its cellular mechanisms against the human hepatoma cell line HepG2. Materials and Methods: The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay was used to evaluate the effect of 10-HDA on the viability of HepG2 cells. The initial and late apoptosis in the HepG2 cells treated with 10-HDA were assessed by the Annexin-V (AV) assay. The level of the gene and protein expression of some apoptosis genes (e.g., caspase-3, Bcl-2-associated X protein (BAX), and B-cell lymphoma protein 2 (Bcl-2)), Poly (ADP-ribose) polymerases (PARP), and miRNA-34a (miR-34a), were measured by real-time PCR and Western blot. Results: The obtained findings revealed that HepG2 cell viability was markedly reduced (p < 0.01) following exposure to 10-HDA in a dose-dependent matter. The calculated half maximal cytotoxic concentration (CC50) value of 10-HDA was 59.6 µg/mL for HepG2 cells, while this value for normal THLE-3 cells was 106.4 µg/mL. We found that 10-HDA markedly elevated (p < 0.01) the percentage of necrotic and apoptotic cells from 0.94 to 9.7 and 27.6%, respectively. The real-time PCR results showed that the expression levels of the caspase-3, Bax, and miR-34a genes were significantly (p < 0.001) elevated. Contrary to these results, a significant (p < 0.01) reduction in the expression level of the Bcl2 gene was observed. The levels of protein expression of Caspase-3, PARP, and Bax were markedly elevated following exposure of HepG2 cells to 10-HDA at ¼ CC50, ½ CC50, and CC50. The level of protein expression of Bcl-2 was markedly reduced following exposure of HepG2 cells to 10-HDA at ¼ CC50, ½ CC50, and CC50 (p < 0.01). Conclusion: The current results confirmed the potent in vitro cytotoxic effects of 10-HDA on HepG2 cells with no significant cytotoxic effects on normal cells. Although its mechanisms of action have not been fully studied, the induction of apoptosis via different pathways was determined as one of the principle mechanisms of action of 10-HDA against HepG2 cells. Nevertheless, additional surveys must be performed to clearly understand the mechanisms of action and safety of this fatty acid. Full article
(This article belongs to the Special Issue Recent Advances in Anticancer Drugs III)
Show Figures

Figure 1

Figure 1
<p>Viability of HepG2 and THLE-3 cells exposed to different concentrations of queen bee acid (10-Hydroxy-2-Decenoic Acid, 10-HDA) or 1 μM doxorubicin (DOX) for two days. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.001 compared with the control; + <span class="html-italic">p</span> &lt; 0.001 compared with DOX. The findings revealed that HepG2 cell viability was markedly reduced (<span class="html-italic">p</span> &lt; 0.01) following exposure to 10-HDA in a dose-dependent manner.</p>
Full article ">Figure 2
<p>Morphological changes in the structure of HepG2 cells treated with queen bee acid (10-Hydroxy-2-Decenoic Acid, 10-HDA) at ½ the half maximal cytotoxic concentration (CC50) concentration for two days (<b>A</b>) and HepG2 cells that were not treated with 10-HDA (<b>B</b>). After exposure of HepG2 cells to 10-HDA (½ CC50 for two days), the cells showed smaller sizes and round shapes with marked cytoplasmic shrinkage (black arrows), while HepG2 cells with no treatment displayed a spindle shape with the same size.</p>
Full article ">Figure 3
<p>The rate of apoptosis and necrotic cells following treatment with the queen bee acid (10-Hydroxy-2-Decenoic Acid, 10-HDA) at ½ the half maximal cytotoxic concentration (CC50) and CC50. Data shown as mean ± SD (n = 3). * <span class="html-italic">p</span> &lt; 0.001. We found that 10-HDA markedly elevated (<span class="html-italic">p</span> &lt; 0.01) the number of necrotic and apoptotic cells. Meanwhile, exposure to 10-HDA at CC50 markedly elevated (<span class="html-italic">p</span> &lt; 0.001) the number of necrotic and apoptotic cells.</p>
Full article ">Figure 4
<p>The levels of gene expression of some apoptosis genes (Caspase-3, Bax, and Bcl-2) and the miR-34a gene in HepG2 cells after exposure to queen bee acid (10-Hydroxy-2-Decenoic Acid, 10-HDA) at ¼ the half maximal cytotoxic concentration (CC50), ½ CC50, and CC50. Data shown as mean ± SD (n = 3). * <span class="html-italic">p</span> &lt; 0.001. Real-time PCR results showed that the expression levels of the caspase-3 and Bax genes were significantly upregulated following exposure to 10-HDA. Contrary to these results, the exposure of HepG2 cells to 10-HDA caused a significant (<span class="html-italic">p</span> &lt; 0.01) reduction in the expression levels of the Bcl2 and miR-34a genes.</p>
Full article ">Figure 5
<p>Western blot (<b>A</b>) and relative protein expression levels (<b>B</b>) of some apoptosis genes (Caspase-3, Bcl-2-associated X protein (BAX), and B-cell lymphoma protein 2 (Bcl-2)) and poly [ADP-ribose] polymerase (PARP) in HepG2 cells after exposure to queen bee acid (10-Hydroxy-2-Decenoic Acid, 10-HDA) at ¼ the half maximal cytotoxic concentration (CC50), ½ CC50, and CC50. Data shown as mean ± SD (n = 3). * <span class="html-italic">p</span> &lt; 0.001. Based on the results of the Western blot assay, the levels of protein expression of Caspase-3, PARP, and Bax was markedly elevated following exposure of HepG2 cells to 10-HDA. In contrast to these results, the level of protein expression of Bcl-2 was markedly reduced following exposure of HepG2 cells to 10-HDA.</p>
Full article ">
16 pages, 2949 KiB  
Article
A Natural Glucan from Black Bean Inhibits Cancer Cell Proliferation via PI3K-Akt and MAPK Pathway
by Peng Li, Yihua Hu, Lingmin Zhan, Jiaqi He, Jingwu Lu, Chunyan Gao, Weijun Du, Aiqin Yue, Jinzhong Zhao and Wuxia Zhang
Molecules 2023, 28(4), 1971; https://doi.org/10.3390/molecules28041971 - 19 Feb 2023
Cited by 3 | Viewed by 2132
Abstract
A natural α-1,6-glucan named BBWPW was identified from black beans. Cell viability assay showed that BBWPW inhibited the proliferation of different cancer cells, especially HeLa cells. Flow cytometry analysis indicated that BBWPW suppressed the HeLa cell cycle in the G2/M phase. Consistently, RT-PCR [...] Read more.
A natural α-1,6-glucan named BBWPW was identified from black beans. Cell viability assay showed that BBWPW inhibited the proliferation of different cancer cells, especially HeLa cells. Flow cytometry analysis indicated that BBWPW suppressed the HeLa cell cycle in the G2/M phase. Consistently, RT-PCR experiments displayed that BBWPW significantly impacts the expression of four marker genes related to the G2/M phase, including p21, CDK1, Cyclin B1, and Survivin. To explore the molecular mechanism of BBWPW to induce cell cycle arrest, a transcriptome-based target inference approach was utilized to predict the potential upstream pathways of BBWPW and it was found that the PI3K-Akt and MAPK signal pathways had the potential to mediate the effects of BBWPW on the cell cycle. Further experimental tests confirmed that BBWPW increased the expression of BAD and AKT and decreased the expression of mTOR and MKK3. These results suggested that BBWPW could regulate the PI3K-Akt and MAPK pathways to induce cell cycle arrest and ultimately inhibit the proliferation of HeLa cells, providing the potential of the black bean glucan to be a natural anticancer drug. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Determination of monosaccharide standards (<b>A</b>) and BBWPW (<b>B</b>).</p>
Full article ">Figure 2
<p>NMR spectra of BBWPW. (<b>A</b>) <sup>1</sup>H NMR, (<b>B</b>) <sup>13</sup>C HMR, (<b>C</b>) DEPT 135, (<b>D</b>) <sup>1</sup>H-<sup>1</sup>H COSY, (<b>E</b>) HSQC NMR, (<b>F</b>) HMBC and (<b>G</b>) NOESY spectra of BBWPW.</p>
Full article ">Figure 3
<p>Effects of BBWPW on different cancer cells. BGC-823, HeLa, NCI-H460 and MCF-7 cancer cells were treated with different concentrations of BBWPW for 24 h, determined inhibition rate by MTT method (<b>A</b>) and observed the effect of BBWPW on HeLa cell morphology (<b>B</b>). <span class="html-italic">n</span> = 6.</p>
Full article ">Figure 4
<p>Cell cycle arrest of HeLa cells induced by BBWPW was detected. After being treated with PBS (<b>A</b>) or 400 μg/mL BBWPW (<b>B</b>) for 24 h, the cell-cycle phase of HeLa cells was examined by flow cytometry with PI staining. (<b>C</b>) The cell cycle arrest rate in different phases. <span class="html-italic">n</span> = 3, (**) represent <span class="html-italic">p</span> &lt; 0.01 compared with the PBS group.</p>
Full article ">Figure 5
<p>The effects of BBWPW on mRNA expression of cell cycle-related genes in Hela cells. The mRNA expression of genes was examined after treatment of 400 µg/mL BBWPW for 6 h (<b>A</b>), 12 h (<b>B</b>) and 24 h (<b>C</b>). PBS as the control group. <span class="html-italic">n</span> = 3. (***) <span class="html-italic">p</span> &lt; 0.001, (**) <span class="html-italic">p</span> &lt; 0.01 and (*) <span class="html-italic">p</span> &lt; 0.05 compared with the control group.</p>
Full article ">Figure 6
<p>Analysis of RNA-seq data. (<b>A</b>) Hierarchical clustering of the samples by genes. In the heatmap, the 50 genes with the highest variance across samples were used. (<b>B</b>) Functional annotations of differential genes. Cell cycle pathways were indicated with red arrows. (<b>C</b>) Functional annotations of targets predicted by the transcriptome-based multi-scale network pharmacological platform. PI3k and MAPK pathways were indicated with red arrows. <span class="html-italic">n</span> = 2.</p>
Full article ">Figure 7
<p>The mRNA expression of pathway-related genes in HeLa cells treated by BBWPW. The mRNA expression of genes was examined after treatment of 400 µg/mL BBWPW for 6 h (<b>A</b>), 12 h (<b>B</b>) and 24 h (<b>C</b>). PBS as the control group. <span class="html-italic">n</span> =3. (***) <span class="html-italic">p</span> &lt; 0.001, (**) <span class="html-italic">p</span> &lt; 0.01 and (*) <span class="html-italic">p</span> &lt; 0.05 compared with the control group.</p>
Full article ">
Previous Issue
Next Issue
Back to TopTop